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There are many promising treatments for neurological disorders. The work in this 
dissertation is aimed at addressing some of the issues associated with delivery of drugs to the 
brain. A major focus of this work is the study of transport phenomena of therapeutic agents 
through neural tissues. First, we carry out a theoretical analysis to investigate the fluid mechanics 
in the perivascular space (PVS). Our calculations indicate that peristaltic motion of the blood 
vessel walls can facilitate fluid and solute transport in the PVS. We then consider the impact of 
ultrasound exposure on neural drug delivery. We find that under certain conditions two acoustic 
waves can coexist and one of them has an extremely large penetration depth. We make a third 
analysis on the retro-convection-enhanced drug delivery (R-CED). The model is used to predict 
the pressure distribution, the fluid flow pattern, and the drug concentration profile in R-CED. 
The effectiveness of R-CED to achieve a large treatment volume is called into question. We 
make a fourth analysis to describe nanoparticle transport in the brain. We explicitly take the 
hydrodynamic interactions between the nanoparticles, the carrying fluid, and the brain tissue into 
account. We devote the fifth analysis to the solid mechanics involved in cerebral 
microhemorrhage. The steady-state and the time-dependent behaviors of the displacement 
vectors are examined. Then, we describe the design and fabrication of a microfluidic probe with 
a capacitive pressure sensor integrated at its tip. Such a device should be able to monitor the tip 
 
  
pressure in convection-enhanced drug delivery (CED) and serve as an indicator of the onset of 
serious backflow problems or other failures. Finally, we present the fabrication and 
characterization of a micromachined dissolved oxygen sensor based on solid polymer electrolyte. 
The small size of the whole device and the simplicity of the fabrication process make these 
devices promising for medical uses. Single devices are shown to have decent performances in 
terms of long term stability, reliability, hysteresis, linearity, and sensitivity. Variations among 
different devices are characterized and correlated and methods for reducing such variations are 
proposed. 
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 CHAPTER 1 
 
INTRODUCTION 
 
Neural drug delivery has been an intensive topic of research in recent years due to its 
importance in clinical medicine. Many promising treatments for brain diseases exist, but the 
efficacies of these therapies are often limited by the difficulty of delivering drugs to the afflicted 
area in the brain due to the presence of the blood brain barrier (BBB). The BBB is a separation 
between the circulating blood and the brain extracellular matrix. Tight junctions formed between 
endothelial cells prevent systemically administered drugs from going across the blood vessel 
walls and entering the brain extracellular space. One of the solutions toward better therapeutic 
strategies is to gain deeper understandings of the transport phenomena occurring in the brain. 
The work presented in this dissertation is mainly concerned with the fluid mechanics and mass 
transfer issues involved in brain drug delivery. 
Chapter 2 of this dissertation deals with the fluid mechanics in the perivascular space 
(PVS). PVS within the brain is an important pathway for interstitial fluid (ISF) and solute 
transport. Fluid flows in the PVS can affect these transport processes and have significant 
impacts on physiology. We carry out a theoretical analysis to investigate the fluid flows in the 
PVS. With certain assumptions and approximations, we are able to find an analytical solution to 
the problem. We discuss the physical meanings of the solution and particularly examine the 
consequences of the induced fluid flow in the context of convection-enhanced delivery (CED). 
We conclude that peristaltic motions of the blood vessel walls can facilitate fluid and solute 
transport in the PVS. 
In chapter 3, we carry out a theoretical analysis on ultrasound assisted brain drug 
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 delivery. The brain tissue is modeled as a fluid-saturated poroelastic medium. Using a 
perturbation approach, we are able to linearize the governing equations and obtain an analytical 
solution. Low-power ultrasound propagates in the medium as mechanical waves, but dissipates 
due to the frictional forces between the fluid phase and the solid phase. The important variables 
regarding to drug delivery are the penetration depth and the amplitude of the ultrasound. The 
dependencies of these two variables on tissue properties and operating conditions (e.g. 
frequency, power) are discussed in detail. We have two major findings. The first is that low-
power ultrasound can enhance drug penetration into the brain tissue by inducing local fluid 
mixing. The second is that under certain conditions two acoustic waves can coexist and one of 
them has an extremely large penetration depth. 
In chapter 4, we carry out a theoretical analysis on retro-convection-enhanced drug 
delivery (R-CED). R-CED is an emerging technique to overcome the blood brain barrier (BBB). 
It creates a pressure difference between the blood stream and the extracellular fluid by 
withdrawing fluid out of the brain. This pressure difference generates a convective flow across 
the blood vessel wall and partially opens the BBB. In this chapter, we develope a mathematical 
model to understand the fluid mechanics and mass transfer in the interstitium of brain tissue 
involved in R-CED. Analytical and numerical solutions are obtained. The model is used to 
predict the pressure distribution, the fluid flow pattern, and the drug concentration profile. Three 
kinds of microdialysis membranes used in R-CED protocols are analyzed in detail. While fluid 
flow is found to be independent of the choice of membranes, mass transfer is found to be highly 
dependent on the choice of membranes. Sensitivity analysis over a wide range of parameter 
values is carried out. Although R-CED is efficacious in generating fluid flows in the brain tissue, 
it seems that it does not lead to a large treatment volume and needs to be re-examined and re-
evaluated experimentally. 
2 
 In chapter 5, we carry out a theoretical analysis on nanoparticle transport in the brain. 
The convection-enhanced distribution of small molecules in the brain is relatively well-
understood from previous studies. The given assumption is that the hydrodynamic interactions 
between the small molecules and the carrying fluid are negligible. However, this assumption is 
no longer valid when applied to nanoparticles. Previous CED experiments have shown that the 
distribution and transport of nanoparicles in the brain is different from small molecules. In this 
chapter, we present a simple mathematical model to describe the transport behavior of 
nanoparticles in CED. This model explicitly takes the hydrodynamic interactions between the 
nanoparticles, the carrying fluid, and the brain tissue into account. Using this model, we are able 
to show how the volume of distribution is dependent on the sizes and the surface properties of 
the infused nanoparticles. In particular, the volume of distribution is sensitive on the surface 
properties of these nanoparticles. 
Chapter 6 addresses a different issue with the brain. It deals with cerebral 
microhemorrhage. There are few effective treatments or preventative strategies for hemorrhagic 
microvascular lesions. Clinical evidence has revealed that microhemorrhage plays an important 
role in several brain dysfunctions such as elderly dementia. The lack of good animal models has 
greatly impeded our understanding on this subject. However, advances in modern optical 
techniques have allowed researchers to induce single-vessel hemorrhages in the cortex of 
rodents. Observations from these animal models provide us with an excellent opportunity to 
study the progression of hemorrhage related diseases and evaluate the effectiveness of potential 
therapeutics. In this chapter, we present mathematical models, derived from both fundamental 
considerations and empirical correlations, to describe the statics and the dynamics in cerebral 
microhemorrhage and compare the models with the experimental data. 
In chapter 7, we describe the design and fabrication of a microfluidic probe with an 
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integrated capacitive pressure sensor. Several researchers have created microfluidic probes for 
use in CED. These devices can reduce backflow and minimize the initial tissue damage due to 
insertion. An integrated pressure sensor at the probe tip will be beneficial if it can be added by 
microfabrication techniques because pressure drops are often good indicators of the onset of 
serious backflow problems or other failures. Such a device should be able to monitor the tip 
pressure rather than an upstream pressure because, more often than not, it is desirable that the 
pressure reading only reflects flow through the tissue rather than flow through the syringe, 
needle, and tissue. Detailed designs and fabrication processes are presented in this chapter. The 
difficulties and problems encountered in the actual fabrication trials are also analyzed. 
In the last chapter, we describe the fabrication and characterization of silicon 
microprobes to measure dissolved oxygen levels. The sensors are prepared by overlaying 
platinum thin film electrodes with a solid state proton conductive matrix (PCM) coating. The 
platinum thin film electrodes are fabricated on silicon substrates by standard photolithographic 
techniques while the PCM coating is achieved by drop-casting methods. The size and materials 
of the device make it potentially suitable for medical implantation. The devices are tested in 
deionized water (DI water), phosphate buffered saline (PBS), and bovine blood serum (BBS). 
Through linear sweep voltammetry (LSV), single devices are shown to have decent 
performances in terms of long term stability, reliability, hysteresis, linearity, and sensitivity. 
Variations among different devices are characterized and correlated. The simplicity and cost 
effectiveness of the fabrication and packaging procedures and the decent in vitro performances 
of these devices make them good candidates as miniaturized, disposable, and implantable 
dissolved oxygen sensors for biological and biomedical use. 
 CHAPTER 2 
 
FLUID MECHANICS IN THE PERIVASCULAR SPACE 
 
2.1 Introduction 
 
Many promising therapeutic compounds for the treatment of neural disorders do not 
readily cross the blood-brain barrier when they are administered systemically.  As a result, some 
alternative methods have been developed to deliver compounds locally to neural tissue.  
Convection-enhanced delivery (CED) is a novel method for in which compounds are infused 
directly into the brain parenchyma through a needle or cannula that is inserted into the brain 
through a small hole in the skull (Bobo et al., 1994).  The infusion establishes a pressure gradient 
in the tissue, which induces a flow of infused fluid in the radial direction away from the tip of the 
needle.  Convection enhances the transport rate of compounds compared with diffusion, 
especially near the needle or cannula where convective forces are dominant.  A variety of 
compounds have been delivered using CED in preclinical and clinical studies, including small 
molecules, chemotherapeutics, proteins, viral vectors, and drug-containing liposomes and other 
nanoparticles. 
The results of studies in animals and humans show that controlling the spatial distribution 
of infused compounds is a critical challenge in CED.  Heterogeneities in neural tissue structures 
lead to corresponding spatial variations in tissue hydraulic conductivity, which can cause fluid to 
flow preferentially in certain directions or along certain paths.  It has long been known that tracer 
compounds and other solutes are transported preferentially along perivascular spaces in the 
cerebral cortex.  The perivascular spaces are extensions of the subarachnoid space that resemble 
5 
 thin annular regions outside blood vessels that penetrate the cortex.  The perivascular spaces may 
serve as preferred conduits for flow of cerebral spinal fluid, and they may provide paths for 
drainage of excess fluid associated with cerebral edema.  During CED therapy, preferential flow 
of infused fluid along the perivascular spaces could affect the overall spatial distribution of 
therapeutic compounds and could provide a route for infused compounds to escape the tissue 
volume targeted for therapy. 
The hydraulic conductivity of the perivascular spaces presumably is greater than that of 
white or gray matter.  However, there is evidence that suggests that pulsations of the blood vessel 
associated with the heartbeat may help propel infused material through the perivascular space.  
Hadaczek et al (2006) studied the distribution of liposomes infused during CED in rats.  When 
the animal’s heart rate and blood pressure were artificially lowered during CED, which 
presumably lowered the frequency and amplitude of blood vessel pulsations, the volume of 
distribution of infused liposomes was also reduced.  They called the transport enhancement 
associated with blood vessel pulsation “perivascular pumping.” 
Fluid flows induced by peristalsis have been extensively studied in the literature. A 
classical review can be found in Jaffrin and Shapiro (1971). For mathematical tractability and 
simplicity most researchers have taken the peristaltic waves as an infinite train of sinusoids. 
When the ratio of the wave amplitude to the mean half-width of the flow channel is assumed to 
be small, a perturbation analysis can be developed with this ratio as the small parameter, and 
semi-numerical solutions can be obtained. When the ratio of the wavelength to the half-width of 
the channel is assumed to be large, lubrication approximations can be applied and analytical 
solutions can be obtained in some circumstances.  Alternatively, computational fluid dynamics 
can be used to solve directly the Navier-Stokes equations with complex boundary geometry and 
boundary conditions and with arbitrary peristaltic waveforms (Bilston et al. 2003). 
6 
 Much of the work in this area has been aimed at understanding biological and 
physiological processes.  For example, Shapiro et al. (1969) applied a model of peristalsis to the 
ureter and used the model to investigate the physiological implications of reflux and fluid bolus 
trapping phenomena.  Mishra and Rao (2004) modeled fluid flow in the gastrointestinal tract by 
studying the peristaltic transport in a channel with a porous peripheral layer.  Bilston et al. (2003) 
carried out a detailed numerical analysis of cerebrospinal fluid flow along the PVS in the spinal 
cord.  Schley et al. (2006) constructed a mathematical model to test the hypothesis that 
perivascular drainage of interstitial fluids and solutes out of the brain tissue was driven by 
pulsations of blood vessel walls. 
In this chapter, we develop a model of fluid flow in the cerebral perivascular space 
induced by peristaltic motion of the blood vessel walls and show how the peristaltic flow 
interacts with the local flow associated with a CED infusion.  Our goals are to show how various 
physiological parameters, especially those whose values are uncertain and difficult to estimate, 
affect fluid transport and to develop a result that could be used to account for perivascular 
transport in numerical simulations of CED infusions. 
 
2.2 Mathematical Model 
 
The perivascular space (PVS) is modeled as a thin, annular, fluid-filled porous medium 
surrounding a blood vessel (Figure 2.1).  We choose a cylindrical coordinate system such that the 
z axis is coincident with the blood vessel centerline.  To simplify  
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Figure 2.1: Geometry of the problem. 
 
the analysis, we assume that both the inner and outer walls of the PVS are impermeable to fluid.  
The outer wall of the annulus is fixed at 2r R= .  The location of the inner wall of the annulus, 
which corresponds to the blood vessel inner wall, is given by h(t,z), the radial coordinate of the 
point with an axial coordinate z on the inner wall at time t.  To introduce peristalsis, we assume 
the blood vessel oscillates according to ( )( )1 sin 2 /R b z ct( , )h t z π λ= + −
/
, which represents a 
sinusoidal peristaltic wave with mean radius R1, half amplitude b, wavelength λ, and wave speed 
c travelling in the +z direction.  The frequency of this wave is f c λ= .  The porous medium 
representing the PVS is assumed to have constant porosity φ  and Darcy permeability κ.  The 
fluid that saturates the PVS is assumed to be Newtonian and incompressible and have constant 
viscosity μ and density ρ. 
In an inertial reference frame in which the porous medium moves with velocity mv , the 
governing equation is the generalized Brinkman-extended Darcy equation (Brinkman, 1947; 
Nield and Bejan, 1998; Edelman, 1999) 
8 
 ( mv v v p v vt φμρ κ∂⎛ ⎞+ ⋅ = − − −⎜ ⎟∂⎝ ⎠∇ ∇ ) .  (2.1) 
Equation (2.1) is valid in any inertial reference frame (as opposed to the original Brinkman-
extended Darcy equation which is only valid when the porous medium is stationary in the chosen 
reference frame). 
The equation of continuity is 
0v⋅ =∇ .  (2.2) 
Coordinate transformations often are useful in solving peristalsis-related problems (see, for 
example, Shapiro et al., 1969).  Instead of working in the laboratory frame Σ in which the porous 
medium (the PVS) is stationary and the peristaltic wave is traveling, we switch to the wave 
frame Σ’ in which the peristaltic wave appears stationary and the porous medium is traveling. 
The coordinate transformations are ' , ' , ' , 'r r z z ct t tθ θ= = = − =
, ' , 'r r z zv v v v cθ θ= = = −
, and the corresponding 
velocity transformations are .  An immediate advantage of working 
in the wave frame Σ’ is that the wave form on the inner wall in Σ’ is expressed as 
'v v
)(1( ', ') sin 2 '/h t z R b zπ λ= + , which is independent of time.  Another advantage of working in 
Σ’ is that the periodic motion of the fluid in Σ is transformed into a steady-state flow in Σ’ 
(Shapiro et al., 1969). 
Axisymmetry of the problem dictates that ''v θ 0=  and 0'θ
∂ =∂ .  The simplified equations in Σ’ 
are as follows: 
r’ component      '' '
' ' '' '
' ' '
r r
r z
v v pv v
r z r
φμρ κ
∂ ∂ ∂⎡ ⎤+ = − −⎢ ⎥∂ ∂ ∂⎣ ⎦ ' 'rv  (2.3) 
z’ component      ' '' ' '
' ' '' ' '
' ' '
z z
r z z
v v pv v v
r z z
cφμ φρ μκ κ
∂ ∂ ∂⎡ ⎤+ = − − −⎢ ⎥∂ ∂ ∂⎣ ⎦  (2.4) 
Next we impose the lubrication approximation.  This approximation is usually applied to thin 
9 
 film flows in empty spaces, rather than spaces filled by a porous medium. 
Table 2.1: Values for the parameters used in the model. 
Parameter Symbol Value Reference
Inner radius R1 51 10−×  m Lightfoot, 1973.
Outer radius R2 51.1 10−×  m Ichimura et al., 1991. 
Wave amplitude b 75 10−×  m 
72.5 10−×  m 
(baseline) 
71.25 10−×  m 
Bilston et al., 2003. 
Wave speed c 1 m·s-1 Gladdish et al., 2005; Hoeks et al., 1999; 
Lightfoot 1973. 
Wave frequency f 5 Hz Hadaczek et al., 2006. 
Viscosity μ -49 10×  Pa·s Bloomfield, 1998. 
Hydraulic 
permeability 
K 122 10−×  m4·N-1·s-1 
112 10−×  m4·N-1·s-1 
(baseline) 
102 10−×  m4·N-1·s-1 
 
Neeves et al., 2006; Smith and 
Humphrey, 2007. 
Porosity φ  0.2 Sarntinoranont et al., 2003; 
Sarntinoranont et al., 2006. 
 
However, it can be shown that under the conditions Re / 1cρ κ μλ=    and 2 / 1Rβ λ=    
(which can be verified with numbers from Table 2.1), the governing  
10 
 equations can be simplified to 
' 0
'
p
r
∂ =∂  and  (2.5) 
'
' '
' z
p cv
z
φμ φμ
κ κ
∂ = − −∂ .   (2.6) 
Equation (2.5) leads to 
( )' ' 'p p z=   (2.7) 
Equation (2.6) leads to 
( )' '' ' 'z
dpv z
dz
κ
φμ= − − c
' 'dr
  (2.8) 
In the wave frame Σ’, the volumetric flow rate is a constant, which means that 
 is independent of z’.  Substituting (2.8) into the expression for the flow 
rate and carrying out the integration gives 
( )
2
''
' ' 2
R
zh z
Q v rπ= ⋅∫
( )2 22 '' ' '
dpQ R h z
dz
κπ φμ
⎛ ⎞⎡ ⎤= − − −⎜ ⎟⎣ ⎦ ⎝ ⎠c .  (2.9) 
Solving (2.9) for the pressure gradient gives, 
( )2 22
' '
' '
dp Q c
dz R h z
φμ
κ π
⎧ ⎫⎪= − +⎨ ⎡ ⎤−⎪ ⎪⎣ ⎦⎩ ⎭
⎪⎬ .   (2.10) 
Since h(z') is a periodic function of z' with period λ, (2.10) shows that  is also a periodic 
function of z' with a period of λ. The integral of  with respect to z' on any interval with 
length λ should be a constant 
'/ 'dp dz
'/ 'dp dz
'pλΔ  independent of the starting point of the interval.  Some 
straightforward calculations give the following result for 'pλΔ : 
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 2 2 2 2 2
2
1 1
2 2 2 2
' 1 1' 1
4
1 1
c Qp
cR R b R b
R R R R
λ
φ μλ
κ π
⎧ ⎫⎡ ⎤⎪ ⎪⎢ ⎥⎪ ⎪⎢ ⎥⎪ ⎪Δ = − + −⎨ ⎬⎢ ⎥⎪ ⎪⎢ ⎥⎛ ⎞ ⎛ ⎞ ⎛ ⎞ ⎛ ⎞− − + −⎪ ⎪⎜ ⎟ ⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎢ ⎥⎢ ⎥⎝ ⎠ ⎝ ⎠ ⎝ ⎠ ⎝ ⎠⎪ ⎪⎣ ⎦⎩ ⎭
. (2.11) 
In the laboratory frame Σ, the pressure change per wavelength 'p pλ λΔ = Δ .  The volumetric flow 
rate at time t across a cross-section at z is 
( ) ( )( ) ( 2' 2' c R hπφ+ )2 2 2( , ) ( , ) 1, 2 2 ' ' 2R Rz zh t z h t zQ t z v rdr v z c rdr Qπ φ πφ φ= = + = −∫ ∫ , where 
(1 2( , ) sinh h t z R b z ctπλ
⎛= = + −⎜⎝ ⎠)
⎞⎟ .  Substituting these results in (2.11) and solving for Q(t,z) 
gives 
( ) (
2
2
2 2
2
2 2 2 2
1 1
2 2 2 2
2 1
, 1 1
1 1
pcR
cQ t z c R h
R b R b
R R R R
λκπφ φ μλ πφ
⎛ ⎞Δ +⎜ ⎟⎝ ⎠= − + −
+
⎛ ⎞ ⎛ ⎞ ⎛ ⎞ ⎛ ⎞− − + −⎜ ⎟ ⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠ ⎝ ⎠ ⎝ ⎠
)  (2.12) 
A time-averaged flow rate can be defined as ( ) ( )
0
1 ,
T
Q z Q t z dt
T
= ∫ .  After a short calculation, 
we find that the volumetric flow rate is independent of z and given by 
2 2
2 1
2
2 2
2 2 2 2
1 1
2 2 2 2
2( 1)
111 1 2
1 1
p
R bcQ cR
R R
R b R b
R R R R
λκ
ε μλπφ
⎧ ⎫⎪ ⎪⎪ ⎪Δ− −⎪ ⎪⎛ ⎞ ⎛ ⎞⎪ ⎪= +⎨ ⎬⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠⎪ ⎪+⎪ ⎪⎛ ⎞ ⎛ ⎞ ⎛ ⎞ ⎛ ⎞− − + −⎪ ⎪⎜ ⎟ ⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎪ ⎪⎝ ⎠ ⎝ ⎠ ⎝ ⎠ ⎝ ⎠⎩ ⎭
− − . (2.13) 
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 2.3 Results and Discussion 
 
At first glance, the lubrication approximation has reduced the nonlinear governing 
equations to a linear form, and it is tempting to solve the problem by using the superposition 
principle, i.e. the total volumetric flow rate is the sum of contributions from the pressure gradient 
and the peristaltic movement of the boundary.  In the wave frame Σ’ the reduced governing 
equation is inhomogenous (equation (2.6)), while in the laboratory frame Σ the boundary is 
moving. These complications make the superposition principle inapplicable in either reference 
frame.  In fact, the pressure gradient and the peristaltic wave are coupled in the solution. 
To illustrate this point, it is helpful to consider the special case where  is very small.  
In this case, a Taylors expansion in of the right side of (2.13) gives to second order in 
: 
2/b R
2/b R
2/b R
2
1
2 2 2
2 21 1
2 2
2 2 21
2
1 3
11 ( 1) 1
2
2 1
R
RR b p RQ cR
R R c RR
R
λκπφ φ μλ
⎧ ⎫⎡ ⎤⎛ ⎞⎪ ⎪⎢ ⎥+ ⎜ ⎟⎪ ⎪⎢ ⎥⎛ ⎞ ⎛ ⎞ ⎛ ⎞ ⎛ ⎞Δ⎪ ⎪⎝ ⎠− − − − + − −⎢ ⎥⎨ ⎬⎜ ⎟ ⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎛ ⎞⎝ ⎠ ⎝ ⎠ ⎝ ⎠ ⎝ ⎠⎛ ⎞⎢ ⎥⎪ ⎪⎜ ⎟− ⎜ ⎟⎢ ⎥⎪ ⎪⎜ ⎟⎝ ⎠⎢ ⎥⎝ ⎠⎪ ⎪⎣ ⎦⎩ ⎭
 
2
2
b
R
. (2.14) 
Equation (2.14) can be rewritten as 
2 2
1 1
2 2
2 2 21
2 2 2
2 21 1
2 2
2 1 3
1
1 2 1
R R
R R
2
2
R p b bQ cR
R c R R cR R
R R
λ λκ κπφ pφ μλ φ μλ
⎧ ⎫⎛ ⎞ ⎛ ⎞⎪ ⎪+⎜ ⎟ ⎜ ⎟⎛ ⎞⎪ ⎪⎛ ⎞ ⎛ ⎞ ⎛ ⎞⎛ ⎞Δ Δ⎪ ⎪⎝ ⎠ ⎝ ⎠⎜ ⎟− − + +⎨ ⎬⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎜ ⎟⎜ ⎟ ⎛ ⎞⎛ ⎞⎝ ⎠⎝ ⎠ ⎝ ⎠ ⎝ ⎠⎛ ⎞⎪ ⎪⎝ ⎠ − ⎜ ⎟−⎜ ⎟ ⎜ ⎟⎪ ⎪⎜ ⎟⎝ ⎠ ⎝ ⎠⎪ ⎪⎝ ⎠⎩ ⎭
  . (2.15) 
The first term on the right hand side of equation (2.15) comes from the pressure gradient (set b=0 
in equation (2.15)).  This term is the flow rate for pressure-driven flow through an annulus filled 
with the porous medium.  The second term comes from peristaltic wave with very small 
13 
 amplitude (set pλΔ =0 in equation (2.13) and Taylor expand with respect to ). The third 
term represents the coupling between the pressure gradient and the peristaltic wave. This 
coupling term is not necessarily small compared to the second term since we didn’t impose any 
restrictions on the magnitude of 
2/b R
pλΔ . But under the condition that  is small, this coupling 
term is always small compared to the first term, regardless of the magnitude of 
2/b R
pλΔ . 
It is interesting to compare these results with those obtained by Bilston et al. (2003) who 
carried out fluid dynamic simulations to model numerically fluid flow in the PVS in the spinal 
cord. They assumed that the PVS within the spinal cord was an empty space (as opposed to a 
porous medium). From equation (2.13), we see that in our model the flow rate has a linear 
dependence on the pressure gradient, which was also reported by Bilston et al (2003).  In the 
absence of a pressure gradient and for small wave amplitudes, the flow rate is  
2
1
2
22
22
21
2
2
1
R
R b cR
RR
R
π
⎛ ⎞⎜ ⎟ ⎛ ⎞⎝ ⎠ ⋅⎜ ⎟⎛ ⎞ ⎝ ⎠− ⎜ ⎟⎝ ⎠
.   
This flow rate is proportional to the wave speed, which was also reported by Bilston et al (2003).  
However, this flow rate is proportional to the square of the wave amplitude, rather than the linear 
relationship reported by Bilston et al (2003).  Our model predicts that there is a critical adverse 
pressure gradient at which the flow rate drops to zero.  For example, using the values 
 m and  m4·N-1·s-1 from Table 2.1, we find  in equation (2.13) is 
zero for a pressure gradient of  Pa·m-1.  A larger b value and/or a smaller K value will 
give a larger critical adverse pressure gradient value. Bilston et al (2003) reported this pressure 
gradient value as 1.4  Pa·m-1. 
71.25 10b −= × 102 10K −= ×
9.4×
710×
 Q
610
Schley et al. (2006) proposed a mathematical model to explain the reverse perivascular 
14 
 transport of amyloid-β out of the brain.  It can be shown that in our model, the time averaged 
displacement of a tracer particle is always positive regardless of the initial position of the 
particle, which means that there is no reverse transport anywhere in the PVS. Mathematically, 
reverse transport can only happen when 0v× ≠∇ . Yet, it is well-known that Darcy’s flow is 
always irrotational. In our model the PVS within the brain is modeled as a porous medium 
(partially filled with and supported by cells), and we chose 1 μm (Ichimura et al, 1991) as the 
width of the PVS (although its value depends on the size of the blood vessel).  We use equation 
(2.1) to study the bulk fluid flow in this porous medium.  The boundary layer flow cannot be 
studied by equation (2.1) because terms that are important in the boundary layer (i.e. fluidic 
viscous term) are not included in equation (1) (Deen, 1998).  The thickness of this boundary 
layer is on the order of κ , which is 42 nm for K = 2×10-12 m4N-1s-1 and 420 nm for K = 2×10-10 
m4N-1s-1.  Since the thickness of this layer is comparable to the pore size of the porous medium, 
it is feasible to model this layer as non-porous space and use Navier-Stokes equation to study the 
details in this layer.  In fact, this is what Schley et al. (2006) did when they modeled the PVS as 
an empty annulus space with a width of 100-150 nm.  Hence, there are no contradictions between 
our model and their model. 
As mentioned in the introduction, we are particularly interested in the combined effects 
of the peristaltic motion of the blood vessel wall and CED treatment.  In CED, drugs are infused 
directly into the brain tissue through a needle or catheter implanted deep inside the brain.  Owing 
to the elasticity of brain tissue, the tissue during the infusion retracts from the high pressure at 
the needle outlet and forms a fluid-filled cavity at the tip of the needle.  Infused fluid flows from 
the cavity into the surrounding tissue.  The macroscopic (on the length scale of the brain) 
pressure field due to a single point source corresponding to the outlet of the needle was found to 
be (Neeves et al., 2006) 
15 
 ( ) oP aP R
R
⋅= , (2.16) 
where Po is the pressure in a fluid-filled cavity of radius a at the needle tip and R is the distance 
from the source.  A typical value for Po is 7 kPa and a typical value for a is 13 μm (Neeves et al., 
2006). 
At location R the microscopic (on the length scale of a single blood vessel) pressure 
gradient in the radial direction, with respect to the location of the source, is 
2
odP P a
dR R
⋅= −  (2.17) 
The interaction between the peristaltic motion of the blood vessel wall and the CED infusion 
pressure gradient in (2.17) depends on the orientation of the blood vessel under investigation.  
For example, if the blood vessel at location R is oriented perpendicular to the radial direction, the 
external pressure gradient generated by CED will have little influence on the pressure gradient in 
the PVS in the blood vessel direction.  The opposite limit is the case in which the blood vessel 
under investigation at location R is oriented in the radial direction and the peristaltic wave travels 
in the outward radial direction.  In this case, the pressure change per wavelength pλΔ  in equation 
(13) can be calculated as , which translates into 2/oP a Rλ− ⋅ ⋅
( )
2 22
2 1
2
2 2
2 2 2 2
1 1
2 2 2 2
2( 1)
111 1 2
1 1
oP a
R bc RQ R cR
R R
R b R b
R R R R
κ
φ μπφ
⎧ ⎫⎪ ⎪⎪ ⎪−⎪ ⎪⎛ ⎞ ⎛ ⎞⎪ ⎪= +⎨ ⎬⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠⎪ ⎪+⎪ ⎪⎛ ⎞ ⎛ ⎞ ⎛ ⎞ ⎛ ⎞− − + −⎪ ⎪⎜ ⎟ ⎜ ⎟ ⎜ ⎟ ⎜ ⎟⎪ ⎪⎝ ⎠ ⎝ ⎠ ⎝ ⎠ ⎝ ⎠⎩ ⎭
− −  (2.18) 
This result shows that Q  depends on the location R of the blood vessel under investigation.  To 
compare the effects of CED therapy in the presence and in the absence of peristalsis of blood 
vessel walls, we define the following dimensionless number 
16 
 ( ) ( ) ( )( ) 0= 100%b
Q R Q R
PW R
Q R
=− × , (2.19) 
where PW stands for “peristaltic wave”.  This number characterizes the fractional contribution to 
fluid flow from the peristaltic wave.  It can be shown that PW is always non-negative. 
At present, we lack experimental data for exact comparisons with theoretical predictions.  
Hence, we turn to a sensitivity analysis on the parameters involved in the model, especially b and 
K, because there are significant uncertainties in their values.  Figure 2.2 shows values of PW(%) 
as a function of distance R from the infusion needle for three different values of K and b fixed at 
its baseline value of 0.25 μm.  Figure 2.3 shows values of PW(%) as a function of distance R for 
three different values of b and K fixed at its baseline value of 2×10-12 m4·N-1·s-1.  The figures 
show 
  
 
Figure 2.2: PW(%) versus log(R(μm)) for three different K values with baseline b value. 
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Figure 2.3: PW(%) versus log(R(μm)) for three different b values with baseline K value. 
 
that whether fluid transport in the PVS is predominantly driven by CED or by the peristaltic 
wave depends on location R and the particular parameter values of b and K.  In all cases depicted 
in Figure 2.2 and 2.3, at sufficiently large distances from the CED infusion source (~1000 μm) 
the main contribution to fluid transport comes from the peristaltic wave. Note that if the blood 
vessel is oriented perpendicular to the radial direction, the fractional contribution provided by the 
peristaltic wave is always zero with respect to the fluid transport in the radial direction. Near the 
infusion source, whether the peristaltic wave is important or not depends on the particular choice 
of parameter values.  In some cases, the peristaltic wave makes a significant fractional 
contribution to fluid transport near the infusion source.  For example PW(%) is as large as 80% 
near R = a for b = 2.5×10-7 m and K = 2×10-12 m4·N-1·s-1.  It seems reasonable that a lower value 
of the hydraulic permeability K should result in an increased fractional contribution from the 
peristaltic wave, which is indicated in Figure 2.2. b is the half amplitude of the wave.  Also, it 
seems reasonable that a thicker PVS, corresponding to a larger the value of b, should result in an 
18 
 increased fractional contribution from the peristaltic, which is indicated in Figure 2.3.  The 
values of b among the cases in Figure 2.3 differ from each other by a factor of 2, while the values 
of K among the cases in Figure 2.2 differ from each other by a factor of 10.  This suggests that 
system is much more sensitive to the value of b than to the value of K.  In the previous 
discussion, we see that under certain conditions the system is additive (See equation (2.15)). The 
sensitivity of PW to the values of b and K can be understood by noticing that the CED pressure 
driven flow rate (the first term on the right hand side of equation (2.15)) is proportional to K 
while the peristaltic wave driven flow rate (the second term on the right hand side of equation 
(2.15)) is proportional to b2. 
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 CHAPTER 3 
 
ULTRASOUND ASSISTED DRUG DELIVERY 
 
3.1 Introduction 
 
Ultrasound has a long history of use in medicine for diagnostic imaging applications 
(Lindner et al., 2004; Moore et al., 2004). As an imaging tool, it has been widely employed and 
valued for its real time applications, low cost, simplicity, and safety. Recently, there have been 
considerable efforts to deveop therapeutic uses of ultrasound. As a matter of fact, applications of 
ultrasound as a method of therapy came earlier than diagnostic ultrasound (Ng and Liu, 2002). 
As early as the 1930s and 1940s in Europe, therapeutic ultrasound was used as irradiation source 
for generating heat. Current therapeutic applications of ultrasound, either by itself or in 
combination with drugs, span a spectrum, including the treatment of diabetes, stroke, cancer, 
cardiovascular diseases, infections, osteoporosis, thrombosis, glaucoma, nerve damage, skin 
wounds and bone fractures.  
In particular, ultrasound can be utilized to enhance the delivery and effect of therapeutic 
drugs. In one of the earliest such studies, Fellinger and Schmidt (1954) reported the successful 
use of ultrasound in combination with hydrocortisone for the treatment of polyarthritis. The most 
extensively studied example is the use of ultrasound to enhance transdermal drug delivery 
(Lavon and Kost, 2004; Mitragotri, 2004). This technique of driving drug molecules across the 
percutaneous barrier is called ‘phonophoresis’ (Tyle and Agrawala, 1989). More recently, Lewis 
et al. (2007, 2009) have focused on the application of ultrasound in the enhancement of local 
drug delivery, especially to neurological tissues.  
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 Local delivery of therapeutics often allows higher doses to be delivered without side 
effects that restrict dose levels in systemic delivery. Local delivery can be combined with 
controlled release to provide sustained high concentrations of drug in the immediate vicinity of 
affected tissue (Gueri et al., 2004; Panyam and Labhasetwar, 2003; Westphal et al., 2003). Local 
delivery is especially important in treating brain disorders, because most therapeutics 
administered intravenously do not cross the blood-brain barrier.  
Transport enhancement by ultrasound can be explained by a variety of thermal and non-
thermal mechanisms among which acoustic cavitation and bubble-assisted microstreaming are 
the most popular ones (Guzman et al., 2002; Keyhani et al., 2001). Studies in vitro and in vivo 
with animal models have revealed that acoustic cavitation and bubble-assisted microstreaming, if 
not well controlled, can cause tissue damage (Adam et al, 2010; Speed, 2001; Wells, 1977). 
There are few reports on the therapeutic use of low power ultrasound in the absence of cavitation 
and bubble-assisted microstreaming. Low power ultrasound may provide the potential benefits of 
prolonged treatment time without tissue damage and simpler electronic controls that eliminate 
the need of using short pulses to mitigate tissue damage.  
In this chapter, we present a theoretical analysis on the fluid and solid mechanics in a 
poroelastic medium induced by low power ultrasound. The goal is to understand from a 
mathematical and physical point of view, how and to what extent low power ultrasound can 
affect or enhance drug transport in soft tissues. We start with basic mass and momentum 
conservation equations together with appropriate constitutive equations. Linearization of the 
governing equations leads to plane wave solutions of the problem. Numerical analysis with 
parameter values relevant to brain tissues are carried out. We propose that low power ultrasound 
can enhance transport through its local mixing effect. We have also discovered an interesting and 
important phenomenon when the mechanical properties of brain tissue under high frequencies 
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 are varied as input parameters.  
 
3.2 Mathematical Model 
 
We treat brain tissue as a fluid-saturated poroelastic network (Basser, P., 1992; Edelman, 
I.Y., 1999; Netti et al., 1997). 
Mass conservation for the fluid and the solid phases are written as 
( ) ( ) 0f f fvt φρ φρ∂ +∇ ⋅ =∂  (3.1) 
( ) ( )1 1s s vt φ ρ φ ρ
∂ ⎡ ⎤− + ∇ ⋅ − =⎡ ⎤⎣ ⎦ ⎣ ⎦∂ 0s  (3.2) 
where φ  is the porosity, fρ  is the density of the fluid phase, fv  is the velocity in the fluid 
phase, sρ  is the density of the solid phase, and sv  is the velocity in the solid phase. 
Momentum conservation for the fluid and the solid phases are written as 
f f f fv vt
φρ φ σ∂⎛ ⎞+ ⋅∇ = ∇⋅ −∏⎜ ⎟∂⎝ ⎠  (3.3) 
( ) ( )1 1s s s sv vtφ ρ φ σ
∂⎛ ⎞− + ⋅∇ = − ∇ ⋅⎜ ⎟∂⎝ ⎠ + ∏  (3.4) 
where fσ  is the total stress in the fluid phase, sσ  is the total stress in the solid phase, and ∏  is 
the sum of forces exerted by the two phases upon each other. 
The densities of the fluid and solid phases are written as 
( )0 01f f f f fp pρ ρ β⎡ ⎤= + −⎣ ⎦  (3.5) 
.s constρ =  (3.6) 
where fp  is the pressure in the fluid phase, 0fρ  is the reference fluid density, 0fp  is the 
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 reference fluid pressure, and fβ  is the compressibility of the fluid. 
Stress-strain relations for the fluid and the solid phase are written as 
f fp Iσ = −  (3.7) 
where I  is the unit tensor, and  
( )2s s sG Trσ ε λ ε= + I  (3.8) 
where G and λ  are Lame constants for the solid phase. 
The strain tensor sε  satisfies 
( Tv ∇ )12s s s sv vt ε∂⎛ ⎞ ⎡ ⎤+ ⋅∇ = ∇ +⎜ ⎟ ⎢ ⎥⎣ ⎦∂⎝ ⎠  (3.9) 
Furthermore, we can write 
( )2 f sv vφ∏ = Φ −  (3.10) 
where Φ  is the friction coefficient or the inverse of the hydraulic permeability. 
We can linearize this set of equations by the following procedure. 
At equilibrium and in the absence of any external stimuli (e.g. ultrasound), 
0 0 0, , , 0, 0,f f s sp p v v 0φ φ εΦ = Φ = = = = =  
where 0 0,φΦ  and  are constants. 0p
In the presence of external stimuli (e.g. ultrasound), we can decompose the dynamic variables 
into two components: an equilibrium component and a perturbed component, 
0 0 0', ', ', 0 ', 0 ', 0 'f f f f s s s sp p p v v v vφ φ φ ε εΦ = Φ +Φ = + = + = + = + = +  (3.11) 
Here, we take 0f 0p p=  in equation (3.5), where p0 is the atmospheric pressure. In the case of 
low power input into the system by the ultrasound, we can assume that the primed variables are 
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 small, and we will keep them to the first order as an approximation. Rewriting the governing 
equations in terms of the primed variables leads to the following set of equations: 
0 0
' ' ' 0ff f
p
v
t t
φφ β φ∂ ∂+ + ∇ ⋅ =∂ ∂  (3.12) 
( )0' 1 svt ' 0
φ φ∂− + − ∇ ⋅ =∂  (3.13) 
( )0 0 0' ' ' 'f f f f sv p v vtρ φ∂ + ∇ + Φ − =∂ 0  (3.14) 
( ) ( ) ( ) ( )20 0 0 01 ' 1 2 ' ' 's s s s f sv G Tr I vtφ ρ φ ε λ ε φ∂ ⎡ ⎤− − − ∇⋅ + − Φ −⎢ ⎥⎣ ⎦∂ ' 0v =  (3.15) 
( )1' '2 Ts s sv vt ε∂ ⎡ ⎤= ∇ + ∇⎢ ⎥⎣ ⎦∂ '  (3.16) 
For simplicity, we will focus on the case where the dynamic variables only depend on the x 
coordinate (i.e. no y and z coordinate dependence). In this case, we write plane wave solutions 
for any primed variable in the form ( ) ( )' , ' i kx tf x t f e ω−= ⋅ , where f’, k and ω  are constants (We 
use the same symbol f’ after factoring out ( )i kx te ω−  as long as there is no ambiguity.) The 
differential equations (3.12)-(3.16) are then transformed into a set of linear algebraic equations. 
After eliminating ', 'f sv v  and 'sε , we obtain 
( ) 2 02 2 00 0 0
0 0
' '
1
f
f f f f f
ik p i p
ω ρ ωω ρ β ωφ β φφ φ
⎛ ⎞Φ− + + Φ + + =⎜ ⎟−⎝ ⎠
' 0  (3.17) 
( )
2 2
0 02 0 0
0
' '
1
f s
f
v v v
i ik p
K K K
ωφ β ω ρ ωφφ φφ
⎡ ⎤Φ Φ− + + + =⎢ ⎥−⎣ ⎦
' 0  (3.18) 
where 2vK G λ= + . 
If a non-trivial solution for equations (3.17) and (3.18) exists, k2 must be an eigenvalue of the 
following matrix 
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 ( )
2
02 0
0 0 0
0 0
2 2
0 0 0 0
0
1
1
f
f f f
f s
v v v
ii
i i
K K K
ω ρ ωω ρ β ωφ β φ φ
ωφ β ω ρ ωφ
φ
⎡ ⎤Φ+ Φ +⎢ ⎥−⎢ ⎥⎢ ⎥Φ Φ⎢ ⎥+ −⎢ ⎥⎣ ⎦
 (3.19) 
In general, there are four k values to be determined by matrix (3.19). It can be shown that there is 
at least one and at most two k values that are physically allowed and physically independent (See 
Appendix A).  
We choose to set up a Cartesian coordinate system such that the ultrasound excitation 
source is positioned at the origin and the ultrasound propagation direction is the +x direction 
(Note that the physics is independent of the choice and set up of coordinate system). Energy 
conservation requires that the ultrasound cannot amplify itself during propagation. Therefore, the 
physically allowed k value must have a positive real part and a positive imaginary part. A 
positive real part indicates that the ultrasound propagates in the +x direction, and a positive 
imaginary part indicates that the ultrasound decays as it propagates. We substitute such a k value 
obtained from matrix (3.19) back into equations (3.17) and (3.18), and solve for the primed 
variables to obtain 
2
0 0
0 0
'
1
f
f
ip A
ω ρ ω
φ φ
⎛ ⎞Φ= +⎜ ⎟−⎝ ⎠
⋅  (3.20) 
( )2 2 0 0 0' f f fm k iω ρ β ωφ β= − − Φ ⋅ A  (3.21) 
2
0 0
0 0
'
1
f
f x
i kv
k
ω β φ Aω
φ φ
Φ⎛ ⎞= +⎜ ⎟−⎝ ⎠
⋅  (3.22) 
( ) ( )2 2 0 0 0 0' 1s x f f f
Av k i
k
ωω ρ β ωφ β φ= − − − Φ ⋅ −  (3.23) 
where A is an unknown constant. 
To determine the constant A, we use the energy conservation condition. 
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 The mean rate of energy dissipation per unit volume is 
( ) ( ) ( ){ }2 2
0
Re , ,
T
f x s xR x v x t v xT
φ Φ ⎡ ⎤= −⎣ ⎦∫ t dt  (3.24) 
where 2T πω= . 
In the context of the perturbation approximation, 
( ) ( ) ( ){ }
( ) ( )
( ) ( )
( )
2 2
0 0
0
2 20 0
2 2
0 0
2 2 2 Im0 0
Re ' , ' ,
' , ' ,
2
' '
2
' ' (3.25)
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f x s x
f x s x
i kx t
f x s x
k x
f x s x
R x v x t v x
T
v x t v x t
v v e
v v e
ω
φ
φ
φ
φ
−
−
Φ ⎡ ⎤= −⎣ ⎦
Φ= −
Φ= −
Φ= −
∫ t dt
 
where    denotes the modulus of a complex number. 
Substituting equations (3.22) and (3.23) into equation (3.25) gives 
( ) ( )
( )
22
2 2 Im2 20
0 02 2
02 1
k x
f f
A
R x k e
k
ω φ ω ρ βφ
−Φ= +−  (3.26) 
Energy conservation requires 
( ) ( ) ( )
22
22 20
0 02 20
04 Im 1
f f
A
R x dx k
k k
ω φ ω ρ βφ
+∞ ΦΩ = = +−∫  (3.27) 
where Ω  is the power input per unit area by the ultrasound excitation source. 
Solving equation (27) for A  gives 
( ) ( )0
2 2
00 0
2 1 Im
f f
k k
A
k
φ
ω φ ω ρ β
− Ω= Φ+  (3.28) 
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 3.3 Results and Discussion 
 
In principle, the eigenvalues of matrix (3.19) and, thus, k can be obtained in closed forms. 
However, the mathematical formula would be rather lengthy and not very helpful in providing 
physical insights into the problem. Instead, we will discuss some special cases in which the 
eigenvalues of matrix (3.19) can be solved in simple forms. 
 
Special case 1:  or 0 0Φ = ω →∞ . Either 0 0Φ =  or ω →∞  will give the solution 
2 2
1 0f fk ω ρ β= , 2 22 /s vKk . When the frequency of the ultrasound is high enough, the 
equations of motion become non-dispersive and uncoupled. The first solution corresponds to the 
acoustic wave propagating in the fluid phase, and the second solution corresponds to the acoustic 
wave propagating in the solid phase.  
ω ρ=
Special case 2: . The two solutions are 0Φ →∞ 21 0k =  and 
( )2 0 02 0 0 01f vk i K
ωφωφ β φ
⎛ ⎞Φ= Φ +⎜ ⎟−⎝ ⎠
.  
From , we have 21 0k = ( ) ( )' , / ' ,f x s xv x t v x t →1. This does not correspond to a plane wave but a 
net in-phase oscillation of the solid phase with the fluid phase. From 
( )2 0 02 0 0 01f vk i K
ωφωφ β φ
⎛ ⎞Φ= Φ +⎜ ⎟−⎝ ⎠
, 
We have  ( )0
0
' 1 1
'
f x
v f
s x
v
K
v
φ βφ
−→ − + .  
The fact that  implies that the penetration depth ( ) of this wave approaches 
zero. This is due to an infinite friction coefficient and a 180° out-of-phase behavior of the fluid 
2Im k →∞ 21/ Im k
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 velocity and the solid velocity. 
Special case 3: Ф0 is very small but non-zero. The two solutions are 
2
02 2
1 0 0Φ1
f
f f
f
v
i
k
K
ωφ βω ρ β
β
= +
−
, 
( )
( )
2
0 02
2 0
0
1
11
v fs
v
f
v
i K
k
K
K
ωφ β φω ρ
φ β
−= + ⎛ ⎞− −⎜ ⎟⎝ ⎠
Φ .  
It is interesting to notice that when 1/f vKβ ≈ (the fluid and the solid phase have similar 
“compressibility”), the Ф0 correction terms are no longer small and the movement of the fluid 
and the solid phase are strongly coupled despite of a small friction coefficient.  
In general, the eigenvalues of matrix (3.19) cannot be obtained in a simple form and 
numerical solutions are needed. For the purpose of a numerical study, we need the values of the 
various parameters appearing in the equations. As mentioned in the introduction, we use brain 
tissue as a model system (although the above mathematical model is applicable to other soft 
tissues that can be described as a poroelastic network). We summarize in Table 3.1 the nominal 
values to be used for those parameters. With these numbers substituted in matrix (3.19), we get 
one and only one physically allowed k value of  m-1 (the other one represents 
a wave propagating and increasing without bound in the +x direction). 
41.8 10 1.7 10 i× + × 4
Acoustic cavitation occurs when the fluid pressure falls blow its vapor pressure. 
Therefore, the critical power input at which acoustic cavitation occurs can be calculated by 
setting the lowest fluid pressure point during one period to the vapor pressure of that fluid. Water 
vapor pressure at 37℃ is  Pa. We set  in equation (20) to be 
 Pa, and get  m2. From equations (21), (22), 
(23) and (27), we get ,  m·s-1,  m·s-1, and 
 W·m-2.  
36.27 10× 'fp
5 31.01 10 6.27 10× − × = 49.47 10× 142.4 10A −= ×
6m ' 7.9 10−= × 2' 2.1 10f xv −= × 3' 2.5 10s xv −= ×
21.6 10Ω = ×
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Table 3.1: Nominal values for the parameters. 
Parameter Symbol Value References
Ultrasound angular 
frequency 
ω  66.28 10×  
rad·s-1 
Lewis et al., 2007.
Porosity 
0φ  0.2  Sarntinoranont et al., 2003; 
Sarntinoranont et al., 2006. 
Inverse hydraulic 
permeability 
0Φ  115 10×  N·s·m-
4 
Neeves et al., 2006; Smith and Humphrey 
2007. 
Mechanical modulus vK  92.4 10×  Pa Lippert, Rang and Grimm, 2004.
Solid density sρ  31 10×  kg·m-3 N/A
Fluid density 
0fρ  31 10×  kg·m-3 N/A
Fluid compressibility fβ  104.6 10−×  Pa-
1 
Fine and Millero, 1973. 
 
First, we need to check whether the general assumption in Biot’s theory of poroelasticity 
is satisfied with the parameter values listed in Table 1 since our theory is based on Biot’s theory. 
The inverse of the real and the imaginary part of k is about 60 μm, which is the characteristic 
length over which dynamic variables could have significant changes. The pore sizes of brain 
tissues have been estimated to be between 38 and 64 nm (Thorne and Nicholson, 2006), which 
are much smaller than 60 μm. Therefore, the general assumption in Biot’s theory is satisfied and 
we are allowed not only to use continuum mechanics, but also ignore acoustical scattering. 
We also need to clarify several points concerning the constitutive equations used in the 
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 model. First, in equation (3.7), we have neglected the internal fluid viscous term. The ratio of 
such a term to the medium force term scales as 
( )
2
2
0 0
~ 1
f
f
f
f s
v
k
kv v
μ μ
φφ
<<ΦΦ −
,  
where fμ  is the viscosity of the fluid. Therefore, the internal fluid viscous term can be dropped 
with confidence. Second, we took the Lame constants G and λ  in equation (3.8) to be real 
numbers, which means that the stress and the strain of the solid phase are in phase with respect to 
each other. We assume that the solid phase is pure elastic and non-dispersive and lump the 
dispersive effects into the friction between the fluid and the solid phase. In general, the 
magnitudes of G and λ  depend on the frequencies of the harmonic excitations. Third, we took 
the friction coefficient Φ0 to be a real number, which means that the frictional force between the 
fluid and the solid phase is in-phase with the velocity difference. This is not true for very high 
frequency oscillations. In our case, the frequency is low enough to guarantee the in-phase 
behavior (Biot, 1956a; Biot, 1956b; Johnson et al., 1987). In general, the magnitude of Φ0 
depends on the frequencies of the harmonic excitations. In our case, the frequency is low enough 
to guarantee that Φ0 can be treated as independent of the frequency (Johnson et al., 1987). 
Fourth, the dimensionless group 0 ' ' /f f x s x fv vρ 0μ− Φ   is much less than 1, indicating that the 
flow is in the Darcy regime and the Forchheimer generalization is not needed (Nield and Bejan, 
1998). 
To study the fluid transfer in the medium, we define two variables as follows:  
( ) ( ) 20 01 Re ,
T
f xM x v xT
⎡ ⎤= ⎣ ⎦∫ t dt  
and  
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 ( ) ( )
2
1 0
Re ,1 T f xv x tM x d
T x
∂⎡ ⎤= ⎢ ⎥∂⎣ ⎦∫ t .  
The first variable M0(x) is the root mean square of the fluid velocity averaged over time. It 
reflects how fast the transient motion of the fluid phase is. The second variable M1(x) is the root 
mean square of the fluid velocity gradient averaged over time. It reflects how abrupt are changes 
in velocity, which is likely to correlate with the extent of convective mixing of solutes. Notice 
that a net translation of the fluid (plug flow) does not contribute to convective mixing within the 
fluid. With some straightforward algebra, we can show that ( ) ( )Im0 ' /k xf xM x v e−= 2  and 
( ) ( )Im1 ' /k xf xM x kv e−= 2 . At the characteristic length 1/ Imx k= , the numerical value for M0 
is  m·s-1 and that for M1 is  s-1. The inverse of M1 (7.1 ms) has the dimension 
of time and can be considered as the characteristic time for local convective mixing.  
35.5 10−× 21.4 10×
To study the heat transfer in the medium, we define a local Nusselt number 
( ) ( ){ } ( )22 2 Im
0
'1 Re ,
2
T f x k x
f x
T v
Nu x v x t dt eα α
−⎡ ⎤= =⎣ ⎦∫ ,  
where α  is the thermal diffusivity of brain tissue (typically 71.4 10−×  m2·s-1, see Elwassif et al., 
2006). Heat is generated in the medium due to dissipation of mechanical energy carried by the 
ultrasound.  decays exponentially and has a maximal value of  at the origin. 
Therefore, we can conclude that heat transfer in the medium is everywhere dominated by 
conduction. Since the heating source term 
( )Nu x 31.6 10−×
( )R x  decays exponentially, it is expected that 
temperatures near the origin (ultrasound excitation source) will rise much faster than those far 
away from the origin when the ultrasound is applied to the medium. The localized heat 
generation might be able to be used to kill malignant cells in hyperthermia therapy. The increase 
in temperature will also increase the diffusion coefficients of the drug molecules and thus 
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 enhance diffusional transport into soft tissues. 
To study the mass transfer in the medium, we define a local Peclet number 
( ) ( ){ } ( )22 2 Im
0
'1 Re ,
2
T f x k x
f x
T v
Pe x v x t dt e
D D
−⎡ ⎤= =⎣ ⎦∫ ,  
where D is the diffusion coefficient of the drug molecule (typically 111 10−×  m2·s-1, see Morrison 
et al., 1994). At x = 90 μm, Pe = 1. Therefore, mass transfer is dominated by convection within 
the 90 μm of the origin and by diffusion beyond 90 μm. The concentration profile for drug 
molecules is expected to have a convective plateau extending 90 μm into the tissue followed by a 
diffusive tail extending to infinity. Convection and diffusion are not isolated processes and are 
quite often strongly coupled to each other in determining the overall mass transfer behavior of 
the system. It is well known that agitation can reduce the amount of time needed for mixing or 
homogenization. The dimensionless variable Pe(x) can be used to quantify the effects of fluid 
agitation on mass transfer in the porous medium. It characterizes the relative importance of local 
convective fluidic mixing to pure solute diffusion in solute transport. In this sense, D(1+Pe(x)) 
can be considered as a local effective diffusion coefficient. At the characteristic 
length 1/ Imx k= , Pe(x) takes a value of 3.0.  
Next, we examine how the frequency of the excitation source will affect transport. For 
this purpose, we sweep the frequency from 0.5 MHz to 10 MHz (which corresponds to an 
angular frequency from 3.14 MHz to 62.8 MHz) in our numerical calculations. It should be noted 
that the Lame constants of brain tissue are frequency-dependent. However, using the data 
presented by Lippert et al. (2004), we have found that the value of Kv is roughly constant in the 
frequency range specified above (although the respective values of G and λ change significantly). 
The results of this frequency-sweeping study are illustrated in Figure 3.1 – 3.4. In the plots, the 
indices 
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Figure 3.1: Frequency-sweeping results for penetration depth. 
 
 
Figure 3.2: Frequency-sweeping results for M0. 
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Figure 3.3: Frequency-sweeping results for M1. 
 
 
Figure 3.4: Frequency-sweeping results for Pe. 
 
M0, M1, and Pe are the values of the functions M0(x), M1(x), and Pe(x) taken at 1/ Imx k= . 
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 When the frequency is increased, the penetration depth, defined as 1/Imk, increases 
monotonically. Both M0 and M1 increase with frequency. But Pe decreases with frequency, 
especially in the 4 MHz to 10 MHz range. This is because higher frequency leads to shorter 
period. Although the movement of the fluid becomes faster and more violent, it lasts for a shorter 
amount of time. It turns out that the shorter period counters the benefits of faster and more 
violent movement and leads to reduced local convective mixing.  
Finally, we discuss an important numerical phenomenon that we have observed in our 
calculations: the emergence of a second pressure wave under certain circumstances. The 
discussion can be traced back to the high frequency properties of brain tissue. Many researchers 
have attempted to measure the mechanical moduli of brain tissue below 400 Hz using a variety 
of techniques, with different loading rates, strain limits, and various species. However, the 
published results have shown a great degree of disparity (Lippert et al., 2004). The differences 
between reported values from different studies can be as large as two orders of magnitude. We 
have only found one paper reporting high frequency properties of brain tissue (Lippert et al., 
2004). Thus, it seems possible that the actual values of the mechanical moduli of brain tissue 
might be two orders of magnitude larger or smaller than those reported in Lippert et al. (2004). 
When Kv takes a nominal value of  Pa, there is one and only one physically allowed 
pressure wave, which decays as it propagates into tissue. This remains the case for increasing 
values of Kv until Kv reaches a value around . At that value, a second physically 
allowed pressure wave emerges. Mathematically, this happens because when Kv reaches 
 Pa, the number of eigenvalues of matrix (3.19) falling into the upper half of the 
complex plane changes from one to two. The previously physically forbidden wave, which 
grows as it propagates, becomes physically allowed due to a change of sign in Imk for that wave. 
The transition point of Kv is not very far away from its nominal value. The emergence of a 
92.4 10×
101.1 10 Pa×
101.1 10×
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 second physically allowed pressure wave has profound consequences in transport. To 
demonstrate these consequences, we set Kv at  Pa and  Pa, which is a 
reasonable upper limit set by experimental data and experimental variations.  Then, we solve 
numerically for the wavelength 2 /
101.1 10× 112.4 10×
Re kπ , penetration depth 1/ , Ω, M0, M1, and Pe (M0, M1, 
and Pe are calculated at 
Im k
1/ Imx k= ), while imposing the aforementioned critical conditions for 
acoustic cavitation to occur. The results are summarized and compared in Table 3.2. 
 
Table 3.2: Comparison of the wavelength 2 / Re kπ , penetration depth 1 , Ω, M0, M1, and 
Pe. 
Im k/
Kv / Pa Wavelength 
/ m 
Penetration 
depth / m 
Ω / W·m-2 M0 / m·s-1 M1 / s-1 Pe 
2.4×109 3.5×10-4 5.8×10-5 1.6×102 5.5×10-3 1.4×102 3.0 
1.1×1010 2.9×10-3 11 7.2×105 7.5×10-3 14 5.6 
2.4×1011 1.4×10-2 0.38 1.2×105 3.2×10-2 14 1.0×102
 
The first question is: if there are two physically allowed waves, which one will be excited 
preferentially? The most general solution should be a linear combination of the two waves. 
However, if , then on a length scale much greater than , the contribution 
from the k1 wave to the general solution is negligible due to its exponential decay. In our case, 
it’s always true that  when there are two physically allowed waves. Clinically, the 
more important length scale for brain tissue would be millimeters, where the second wave 
dominates. The penetration depth of the second wave is much larger than that of the first wave. 
Additional numerical calculations reveal that the movements of the fluid and the solid phase for 
the second wave are closer to synchronous than those in the first wave in the sense that the 
1Im Imk  
Im  
2k
2k
11/ Im k
1 Imk
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velocity difference between the two phases in the second wave is much smaller, which allows the 
wave to propagate further due to reduced friction. In the presence of the second wave, the 
maximum power input without inducing acoustic cavitation becomes much larger. This can be 
attributed to the fact that the second wave can carry the mechanical energy much deeper into the 
medium and thus alleviate local depressurization, which is the cause of acoustic cavitation. It is 
interesting to note that the intensity levels of ultrasound currently used for therapeutic purposes 
lie in the range of 5×103 - 3×104 W·m-2. The large penetration depth and the large Pe number 
associated with the second wave indicate that mass transport in brain tissue exposed to 
ultrasound is dominated everywhere by local convection induced by the ultrasound. Due to the 
importance and profound clinical implications associated with the emergence of the second 
wave, we urge that more accurate and more extensive experimental studies should be carried out 
to ascertain mechanical properties of brain tissue under high frequencies.
 CHAPTER 4 
 
A COMPUTATIONAL STUDY ON RETRO-CONVECTION-ENHANCED DRUG 
DELIVERY 
 
4.1  Introduction 
 
It is well-known that blood brain barrier (BBB) can prevent intravenously administered 
drug from leaving the blood stream and crossing the vascular walls to penetrate into the brain 
tissue. The potency of most drugs inside the cerebral extracellular space is seriously limited by a 
variety of physiological barriers, including rapid clearance (Groothuis et al., 2007), non-specific 
binding, biotransformation (Saltzman et al., 1991), and high intratumor pressure (Chen et al., 
1999).   
Various approaches have been developed to overcome or circumvent the BBB. Guerin et al. 
(2004) provided a comprehensive review on local drug delivery by biodegradable polymers 
implanted in the resection cavity after brain tumor surgery. Rapoport et al. (2000) conducted 
experiments on osmotic opening of the BBB by intracarotid infusion of a hypertonic arabinose or 
mannitol solution. Bobo et al. (1994) pioneered convection-enhanced delivery (CED) of large as 
well as small molecules into the brain by direct intracerebral infusion. Recently, an alternative 
technique has been invented to overcome the BBB. This method utilizes the inverse procedure of 
a CED protocol and is thus called R-CED. In R-CED, interstitial fluid (ISF) is withdrawn out of 
the brain by an inserted needle. The reduction of the ISF pressure generates a significant 
transendothelial pressure gradient and leads to a significant increase in the bulk flow across the 
capillary wall into the interstitial space. This bulk flow may lead to an enhanced uptake of 
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 systemically administered therapeutic agents. Currently, there are two ways to reduce the ISF 
pressure. DiResta et al. (2000) connected a vacuum source to the surgically inserted needle to 
remove ISF mechanically. Huynh et al. (2007) introduced an implanted microdialysis probe in 
replace of an ordinary needle to extract fluid from the tissue by using a polymeric osmolyte. 
The fluid flow and the mass transfer in the brain tissue have been modeled extensively in 
the literature for CED (Baxter et al., 1989; Morrison et al., 1994). However, there are few reports 
on the mathematical modeling of R-CED. In this chapter, we develop a mathematical model to 
describe the fluid mechanics and mass transfer involved in R-CED. The goal is to use the model 
to produce quantitative predictions on how relevant physiological parameters can affect drug 
transport and distribution, what the potentials R-CED have, and how effective R-CED can be. 
Hopefully, the answers to these questions can help us in the evaluation of R-CED and the 
creation of better therapeutic strategies. 
 
4.2  Mathematical Model 
 
 We assume, for simplicity and mathematical tractability, that the region of brain tissue 
under investigation is a homogenous, isotropic, rigid, and porous medium (Neeves et al., 2006). 
We further assume that the fluid flow is in the steady state. 
Darcy’s law relating the velocity and the pressure gradient is written as 
iv K pφ = − ∇  (4.1) 
where φ  is the tissue porosity,  v  is the fluid velocity, K is the tissue hydraulic permeability, and 
ip  is the interstitial pressure. 
The differential conservation of water (Starling’s law) is written as 
( ) ( )0p iv L s p pφ∇ ⋅ = −  (4.2) 
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 where  is the capillary hydraulic permeability, s is the capillary area per tissue volume, and pL
0p  is the effective Starling pressure. 
Equations (4.1) and (4.2) are closed with respect to v  and ip . 
The interstitial mass transfer is governed by the mass conservation equation (Baxter et al., 1989; 
Morrison et al., 1994) 
( ) ( ) 0 d1
mv
mv
Pe
Ca mv Pe
c cD c cv p sPe k c
t e
φ φ φ∂ −= ∇ ⋅ ∇ −∇ ⋅ + ⋅ −∂ −
e c
)
 (4.3) 
where c is the interstitial concentration, D is the diffusion coefficient, pCa is the capillary 
permeability,  is the plasma concentration of the therapeutic agent under investigation,  is 
the degradation rate constant, and  is a microvasculature Peclet number defined as 
0c dk
mvPe
( ) (0 1p i
mv
Ca
L s p p
Pe
p s
σ− −=  (4.4) 
where σ  is the reflection coefficient.  characterizes the ratio of convective to diffusive flux 
across the capillary wall. 
mvPe
 
4.3  Analytical and Numerical Solutions 
 
4.3.1  Analytical Solutions with Spherical Symmetry 
 
In this subsection, we develop an analytical solution for a simple case. This not only 
provides insights into a special case but also serve the purpose of validating our computer 
simulation codes for later use. Assume spherical symmetry and position the fluid withdrawal 
needle at r = 0. The boundary conditions for equations (4.1) and (4.2) are 
r →∞ , 0ip p→  (4.5) At 
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 ζ= , 2 rvπζ φ =At r 4 Q  (4.6) 
re  is e needlwhe  ζ  radius of th e, and Q is the volumetric flow rate (For fluid infusion, Q is 
.
l expressions for the interstitial pressure and the 
positive  For fluid withdrawal, Q is negative). 
Given these boundary conditions, the analytica
fluid velocity are found to be (Morrison et al., 1994) 
( )0 4 1
r
Qe e
α
α ζ− ⋅
ip p K rπ α= + ⋅+  (4.7) 
( ) 2
1
4 1
r
r
Qev e
r r
αα
ζα
πφ α ζ
− ⋅⎛ ⎞= +⎜ ⎟+ ⎝ ⎠  (4.8) 
where p
L s
K
α ζ= . 
imit In the l 0α → , equations (4.7) and (4.8) can be simplified to 
0i
Qp p= + .9) 
4 Krπ  (4
24r
Qv
rπφ=  (4.10) 
The mass transfer equation (4.3) can be written as 
( )2 21 1c cD r r cv p sPeφ φ φ∂ ∂ ∂ ∂⎛ ⎞= − +⎜ ⎟ 02 2 1
mv
mv
Pe
r Ca mv dPe
c e c k c
t r r r r r e
−⋅ −∂ ∂ ∂ ∂ −⎝ ⎠  (4.11) 
or 
( )2 22 21 1 1
mv
mv
Pe
r Ca mv dPe
c c eD r r cv p sPe k
t r r r r r e
c cφ φ⎛ ⎞∂ ∂ ∂ −= − + ⋅ −⎜ ⎟∂ ∂ ∂ ∂ −⎝ ⎠
% % %% %  (4.12) 
where 
φ ∂
0
cc
c
=% . 
alytical solution, we further assume that To get an an 0, 0,d mvD k Pe= = → ∞ . Then we have 
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 Table 4.1: Parameter values used to test the computer simulation codes. 
Parameter Symbol Value Reference
Capillary hydraulic 
permeability 
pL  1407.1 1 −×  
m3·N-1·s-1 
l., 2006; Samtinoranont et al., Neeves et a
2006. 
Tissue hydrau K 122 10−×  mlic 
permeability 
4·N-
1·s-1 
oranont et al., 2003; Samtinoranont Samtin
et al., 2006. 
Capillary perm pCa 141 10−×eability  m·s-1 Artificial.
Capillary area per 
tissue volume 
s 41 10×  m al., 2006; Rapopo-1 Neeves et rt et al., 2000; 
Samtinoranont et al., 2006. 
Reflection coefficient σ  0.95 Rapoport et al., 2000. 
Tissue porosity φ  0.2 Smith et al., 2007; Zwillinger et al., 2006.
Probe tip radius ζ  503 1 −×  m Artificial.
Diffusion coefficient D 0 Artificial.
Volumetric fluid flow 
rate 
Q 121.6 10−− ×  
m3·s-1 
10.1 minLμ −⋅  fluid withdrawal rate. 
Degradation rate Artificial.
constant 
dk  0
 
( ) ( ) (2 0 021 1r p ic r cv L s p p ct r rφ φ σ∂ ∂= − + − −∂ ∂ )  (4.13) 
Plug equations (4.7) and (4.8) into equation (4.1 r some straightforward algebra, we get 3). Afte
( )
24 4t r r Krπφ πφ∂ ∂
1pL s Qc Q c σ−∂ ∂= − −% %  (4.14) 
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 where 
0
cc
c
=% . 
Equation (4.14) is a quasi-linear partial differential equation and can be solved explicitly by the 
method of characteristics (Saltzman et al., 1991). The solution compatible with zero initial 
concentration and zero concentration gradient at the origin and at infinity is 
( ) ( )0
1
3
3
1
34
4
p
t
L s Q
c d
QwK r
σ
πφ πφ
−
− −=
⎛ ⎞+⎜ ⎟⎝ ⎠
∫% w  (4.15) 
 
4.3.2 Validation of Computer Simulation Codes 
 
Equation (4.12) with ip  and  given by equations (4.7) and (4.8) can be numerically 
integrated by a solver in MATLAB 7.0.4. In order to test our computer simulation codes, we 
choose a set of parameter values listed in Table 4.1 so that we can directly compare the 
numerical results with those calculated from equation (4.15). In our simulation codes, we have 
imposed the initial condition of zero concentration and the boundary conditions of zero 
concentration gradient at 
rv
r ζ=  and at infinity. Numerical simulations for the dimensionless 
concentration  were carried out. The results from simulations are found to match the analytical 
solutions with an error of 3% within r = 0.3 cm and up to t = 20 min (See Figure 4.1) and an 
error of 5% up to t = 60 min.  
c%
 
4.3.3 Numerical Simulations with Axisymmetry 
 
In a more practical and more patient-friendly R-CED procedure, the fluid is removed by a 
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 microdialysis tube (Huynh et al., 2007). Usually, the length of the tube  
is large compared to its radius. For such a situation, axisymmetry is a better  
 
Figure 4.1: Comparison of analytical solutions and numerical solutions of the dimensionless 
concentration. Dots represent numerical solutions while circles represent analytical solutions. 
 
approximation than spherical symmetry. However, it’s impossible to get an analytical solution 
for the concentration with axisymmetry. Due to the similarities between spherical symmetry and 
axisymmetry, we only need to slightly modify the computer simulation codes to accommodate 
the symmetry of the problem and still have confidence in the validity of the codes. In a 
cylindrical coordinate system, we position the axis of the microdialysis tube on the line r = 0. For 
the axisymmetric case, the analogs of equations (4.7), (4.8) and (4.12) are 
( )0 012i
Qp p K
K K
rαπ α α ζ
⎛= + ⋅ ⎜⎝ ⎠
⎞⎟  (4.16) 
where  is the second kind modified Bessel function of order q, Q is the flow rate per unit ( )qK ⋅
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 length along the z direction and ζ  is the outer radius of the microdialysis tube. 
( ) 112r
Qv K r
K
α
πφζ α ζ
⎛ ⎞= ⋅ ⎜ ⎟⎝ ⎠  (4.17) 
( )1 1 1
mv
mv
Pe
r Ca mv dPe
c c eD r rcv p sPe k
t r r r r
c c
e
φ φ φ⎛ ⎞∂ ∂ ∂ −= − + ⋅ −⎜ ⎟∂ ∂ ∂ −⎝ ⎠
% % %% %
r
∂
∂  (4.18) 
At infinity, there is no convective flux, no diffusive flux, and thus no net flux. At the surface of 
the microdialysis probe, the boundary condition is complicated and depends on the property of 
the dialysis membrane. If the membrane is completely permeable to the drug molecules (Note 
that the membrane should always be impermeable to the dialysate), the total flux across the 
membrane under high withdrawal flow rate is equal to the convective flux, i.e. the diffusive flux 
is negligible. If the membrane is impermeable to the drug molecules, the total flux is zero. If the 
membrane is semipermeable to the drug molecules (By “semipermeable”, we mean that the drug 
molecules are able to pass through the membrane, but there is some mass transfer resistance 
across the membrane), the boundary conditions depends on the mass transfer inside the 
micordialysis tube. In the following we discuss these three boundary conditions separately. 
 
① Completely Permeable Membrane 
Zero diffusive flux leads to the boundary condition of 
At r ζ= , 0c
r
∂ =∂  (4.19) 
or 
At r ζ= , 0c
r
∂ =∂
%
 (4.20) 
② Impermeable Membrane 
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 Zero total flux leads to the boundary condition of 
Table 4.2: Parameter values used to simulate the case with axisymmetry. 
Parameter Symbol Value Reference
Capillary hydraulic 
conductivity 
pL  147.1 10−×  
m3·N-1·s-1 
Neeves et al., 2006; 
Samtinoranont et al., 2006 
Tissue hydraulic 
conductivity 
K 122 10−×  
m4·N-1·s-1 
Samtinoranont et al., 2003; 
Samtinoranont et al., 2006 
Capillary permeability pCa 111.1 10−×  
m·s-1 
Neeves et al., 2006
Capillary area per 
tissue volume 
s 41 10×  m-1 Neeves et al., 2006; Rapoport et 
al., 2000; Samtinoranont et al., 
2006 
Reflection coefficient σ  0.95 Rapoport et al., 2000
Tissue porosity φ  0.2 Smith et al., 2007; Zwillinger et 
al., 2006 
Outer radius of the 
microdialysis tube 
ζ  42.5 10−×  m Morrison et al., 1994
Diffusion coefficient D 111 10−×  
m2·s-1 
Neeves et al., 2006
Flow rate per unit 
length along the z 
direction 
Q 108 10−− ×  
m2·s-1 
10.1 minLμ −⋅  fluid withdrawal 
rate for a 0.2-cm long 
microdialysis membrane 
Degradation rate dk  0 No degradation
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At r ζ= , 0rcD cvr
∂ − =∂  (4.21) 
or 
At r ζ= , 0rcD cvr
∂ − =∂
% %  (4.22) 
③ Semipermeable Membrane 
In general, it’s very difficult to specify an appropriate boundary condition for a semipermeable 
membrane. To simplify the problem, we impose the following boundary conditions, 
At r ζ= , rcD cv fcr
∂ − = −∂ rv  (4.23) 
or 
At r ζ= , r rcD cv f cr
∂ − = −∂
% % v%  (4.24) 
Here 0 1.  corresponds to impermeable membrane and f≤ ≤ 0f = 1f =  corresponds to 
completely permeable membrane. In the following calculations, we take f to be 0.5 for a 
semipermeable membrane for demonstrational purposes. 
We use the parameter values listed in Table 4.2 to solve for c  as a function of t and r (Figure 4.2 
– 4.4) for the three types of membranes. 
%
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Figure 4.2: Dimensionless concentration profile for completely permeable membrane. 
 
 
Figure 4.3: Dimensionless concentration profile for impermeable membrane. 
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Figure 4.4: Dimensionless concentration profile for semipermeable membrane. 
 
4.4 Sensitivity Analysis 
 
At the current stage, we still lack experimental data for direct comparison with theoretical 
predictions. Yet the mathematical model can be used to carry out a sensitivity analysis on the 
various parameters involved. The utility of sensitivity analysis lies in the fact that a system is 
sometimes more sensitive to change in one parameter than another. Tissue properties such as 
capillary permeability and reflection coefficient can vary, depending on physiological conditions, 
e.g. healthy tissue or malignant tumor. The pharmacodynamics such as diffusion and elimination 
can vary, depending on the properties of the drug molecules, e.g. molecular size, surface coating. 
We choose Cap ,σ , D, kd, K, and Q as the varied parameters and plot the dimensionless 
concentration profile for an impermeable membrane at a single time point t = 60 min (Figure 4.5 
– 4.10). 
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Figure 4.5: Dimensionless concentration profile at t = 60 min for different values of capillary 
permeability pCa. Baseline values are listed in Table 4.2. 
 
 
Figure 4.6: Dimensionless concentration profile at t = 60 min for different values of reflection 
coefficient σ. Baseline values are listed in Table 4.2. 
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Figure 4.7: Dimensionless concentration profile at t = 60 min for different values of diffusion 
coefficient D. Baseline values are listed in Table 4.2. 
 
 
Figure 4.8: Dimensionless concentration profile at t = 60 min for different values of degradation 
rate constant kd. Baseline values are listed in Table 4.2. 
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Figure 4.9: Dimensionless concentration profile at t = 60 min for different values of tissue 
hydraulic conductivity K. Baseline values are listed in Table 4.2. 
 
 
Figure 4.10: Dimensionless concentration profile at t = 60 min for different values of fluid 
withdrawal rate Q. Baseline values are listed in Table 4.2. 
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 4.5  Results and Discussion 
 
First, let us have a quick look at the fluid flow issues involved in this problem. Pressure 
and velocity distributions in the interstitium calculated from equations (4.16) and (4.17) for three 
different fluid withdrawal rates with baseline parameter values listed in Table 4.2 are shown in 
Figure 4.11 – 4.12. For any given position, the effective pressure p0-pi as well as the magnitude 
of the fluid velocity –vr is directly proportional to the fluid withdrawal rate. From Figure 4.11 – 
4.12 we can see that for the nominal fluid withdrawal rate of 0.1 μL/min, the effective pressure is 
200 Pa at r = 0.3 cm and the interstitial fluid velocity is 1.6×10-5 cm/s, which are not 
insignificant. The pressure and velocity distributions are independent of the drug properties, 
especially whether the drug molecules can pass through the microdialysis membranes or not. The 
fluid mechanics in R-CED is similar to that in CED, governed by Darcy’s  
 
Figure 4.11: Distribution of interstitial pressure. 
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Figure 4.12: Distribution of interstitial velocity. 
 
law and Starling’s law. 
Now let us turn to the mass transfer issues. The microdialysis membrane separates the 
ISF and the dialysate solution. Water is allowed to pass freely across the membrane. If the 
membrane is completely permeable to the drug molecules, we can get a rather homogeneous 
drug distribution up to 0.3 cm away from the probe (Figure 4.2). But the concentration in the 
interstitium is only several thousandths of that in the blood since most of the drug molecules are 
drained away by the probe and get wasted. If the membrane is impermeable to the drug 
molecules, the drug molecules accumulate near the probe and the concentration quickly builds up 
(Figure 4.3). If the membrane is semipermeable, the situation sits in between as expected (Figure 
4.4). The concentration profiles are indirect reflections of the permeability of the microdialysis 
membranes. 
Since an impermeable membrane is most favorable for drug delivery purposes, we make 
a detailed sensitivity analysis for this type of membrane. We examine the concentration profiles 
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 at a single time point of t = 60 min (Figure 4.5 – 4.10). All trends observed are consistent with 
intuitive arguments. An increase in capillary permeability or a decrease in reflection coefficient 
tends to increase the drug concentration in the intersitium. Smaller diffusion coefficients tend to 
sharpen the concentration profile. In Figure 4.7, notice that the benefit of having a larger 
diffusion coefficient is that the distribution of the drug molecules is more uniform, but the 
penalty is that the absolute value of the concentration becomes smaller. A small degradation rate 
constant has almost no effect on drug distribution while a large degradation rate constant lowers 
the interstitial drug concentration to certain extent. Higher fluid withdrawal rates tend to 
accumulate more drug molecules near the probe tip. It is a little bit surprising that drug 
distribution is rather insensitive to the value of tissue hydraulic permeability since all three 
curves in Figure 4.9 actually overlap each other. In R-CED, the resistivity to fluid flow by 
capillary walls and interstitial structures are connected in parallel and the resistivity is dominated 
by capillary walls. Therefore tissue hydraulic permeability becomes much less important. 
Finally, we would like to compare R-CED with CED in detail. In a CED protocol, drug 
containing fluid is directly infused into brain tissue through an inserted catheter. The drug 
delivery source is located at a single point corresponding to the tip of the infusion catheter. Since 
drug molecules do not have to pass across the capillary walls, the BBB is circumvented. Under 
high infusion rate, forced convection of ISF in the interstitium is the dominant drug distribution 
mechanism near the infusion point. Compared to diffusion, convection has been shown to be able 
to significantly increase the drug distribution volume. An eminent and long-existing problem 
associated with CED is the so-called “backflow” problem. Brain tissue is a poroelastic medium. 
Since there is usually no contact stress between the infusion catheter and the tissue at the 
infusion point, the adjacent tissue is free to move away from the catheter during infusion. This 
movement of the tissue is the cause of reflux of infused solution along the catheter-tissue 
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 interface and the phenomena is called backflow. This is the cause of many treatment induced 
complications in CED. Backflow leads to poor control over the fate of infused drugs which often 
end up in healthy tissue. An immediate advantage of the R-CED therapy is that the backflow 
problem does not exist in R-CED. The direction of the fluid velocity is opposite to that in CED. 
The fluid is sucked toward the microdialysis probe. As a result, tissue adjacent to the probe 
surface tends to move toward that surface and be kept in intimate contact with that surface. 
However, drug molecules do need to pass the BBB in R-CED although to some extent the BBB 
is weakened by pressure gradients across the capillary walls. Also notice that the drug delivery 
source is provided by efflux of fluid from the blood vessels into the interstitium and is thus 
continuously distributed within the tissue. We have already seen that mass transfer pathways and 
mechanisms are quite different in CED and R-CED. From previous discussions, we have seen 
that R-CED is effective in generating convections in the interstitium, no less effective than CED. 
But effective fluid flow does not necessarily translate into effective mass transfer. In R-CED, the 
drug concentration profile depends on the choice of microdialysis membranes. For a completely 
permeable membrane, the drug distribution is uniform all the time over a large distance but stays 
at a fairly low level in the interstitium. This immediately raises concerns on drug toxicities in the 
blood. For a completely impermeable membrane, there is a sharp change in the interstitial drug 
concentration near the fluid withdrawal point. Although the drug concentration might even 
exceed that in the blood near the withdrawal point, the affected volume is rather small, which can 
be attributed to low tissue hydraulic permeability, low capillary hydraulic permeability, and high 
reflection coefficient. There are uncertainties in the values of these parameters. Previous tissue 
hydraulic permeability measurements are mainly based on a CED-like methodology, which may 
underestimate tissue hydraulic permeability due to backflows. Capillary hydraulic permeability 
and/or reflection coefficient may change when there is significant bulk flow across capillary 
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 walls (e.g. change of pore size, significant disruption of endothelial cells). These uncertainties 
are associated with the fundamental mechanical properties of brain tissues and deserve to be 
studied both experimentally and theoretically in further details. 
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 CHAPTER 5 
 
NANOPARTICLE TRANSPORT IN THE BRAIN 
 
5.1  Introduction 
 
Delivery of high-molecular-weight therapeutic compounds and nanoparticle drug carriers 
into a clinically relevant volume of tissue is of particular challenge in the central nervous system 
(CNS) due to the presence of the blood brain barrier (BBB). It has been demonstrated in small 
animal studies that intrathecal, intraventricular, intravascular, and acute parenchymal injections 
can distribute nanoparticles to limited volumes in the brain tissue (Mannes et al., 1998; Muldoon 
et al., 1995; Oldendorf et al., 1974). Intravascular delivery has the simplest procedure and is the 
least invasive delivery approach. Nevertheless, this method fails to deliver into the brain, because 
channels in the BBB are so small that even the passage of small macromolecules is inhibited, let 
alone nanoparticles. Additionally, this technique does not target a specific region of the brain. 
The effectiveness of intrathecally and intraventricularly injected therapeutic agents is limited by 
diffusion. It has been reported that small molecules such as sucrose can penetrate a few 
millimeters into the brain tissue (Fenstermacher et al., 1974; Groothuis et al., 1999; Morrison et 
al., 2001). However, high-molecular-weighted or large-sized therapeutic agents (e.g. 
unmetabolized proteins, gene-carrying vectors) suffer a sharp loss of concentration beyond the 
CSF-tissue interface (Fenstermacher et al., 1974; Morrison et al., 2001; Muldoon et al., 1995). 
As a result, intravascular, intrathecal, and intraventricular injections have not been very 
successful in the clinical setting of the treatment of brain disorders. Another approach that may 
enhance the distribution of nanoparticles in brain tissue is convection-enhanced delivery (CED). 
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 Unlike diffusion, which relies on a concentration gradient, CED relies on the bulk flow to carry 
therapeutic agents through the extracellular space. CED is not restricted by BBB and can achieve 
a relatively homogeneous concentration distribution of the infused compounds in a relatively 
large volume of distribution (Bobo et al., 1994; Broaddus et al., 1998; Chen et al., 1999; Laske et 
al., 1997; Morrison et al., 1994; Neeves et al., 2006). Furthermore, by delivering the complete 
dose at the target site, smaller quantities may be administered than required for systemic dosing, 
thus reducing systemic exposure and toxicity. This method of delivery is also able to carry 
nanoparticles significantly farther than using diffusion alone. 
On the theoretical side, a large amount of work has been carried out to analyze the fluid 
mechanics and mass transfers involved in CED (Basser 1992; Baxter et al., 1989; Morrison et al., 
1994; Netti et al., 1997; Netti et al., 2003). The distribution of small molecules, which are treated 
as tracers in the fluid, is relatively well-understood from these previous studies. The given 
assumption is that the hydrodynamic interactions between the small molecules and the carrying 
fluid are negligible. However, this assumption is no longer valid when applied to nanoparticles. 
Previous CED experiments have shown that the distribution and transport of nanoparicles in the 
brain is different from small molecules. In this chapter, we present a simple mathematical model 
to describe the transport behavior of nanoparticles in CED. This model explicitly takes the 
hydrodynamic interactions between the nanoparticles, the carrying fluid, and the brain tissue into 
account. Using this model, we are able to show how the volume of distribution is dependent on 
the sizes and surface properties of the infused nanoparticles. 
 
5.2  Mathematical Model 
 
We assume, for simplicity and mathematical tractability, that the region of brain tissue 
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 under investigation is a homogenous, isotropic, rigid, and porous medium. We also ignore the 
size distribution of the infused nanoparticles.  
Mass conservation for the fluid phase is written as 
( ) ( ) 0p pnV nV vt φ φ∂ ⎡ ⎤− + ∇ ⋅ − =⎣ ⎦∂ f  (5.1) 
where φ  is the porosity, n is the nanoparticle number density, Vp is the volume per nanoparticle, 
and vf is the fluid velocity.  
Mass conservation for the nanoparticle phase is written as 
( ) 0pnR nvt∂ + ∇ ⋅ =∂  (5.2) 
where R is the retardation factor (Morrison et al., 1994), and vp is the nanoparticle velocity. R 
takes non-hydrodynamic-interactions (e.g. fluid exchange between the intracellular space and the 
extracellular space, linear bindings) into account. 
Momentum conservation for the fluid phase is written as 
( ) ( ) ( )p p pf f f f f
p
nV nV nV
v v p v v v
t
φ μ φ μρ κ κ
− −∂⎛ ⎞+ ⋅∇ = −∇ − − −⎜ ⎟∂⎝ ⎠ p  (5.3) 
where ρf is the density of the fluid, p is the pressure, μ is the viscosity of the fluid, κ is the Darcy 
permeability of the medium, and κp is the analog of κ for the nanoparticle phase. κp depends on 
the size and geometry of the nanoparticle. 
Momentum conservation for the nanoparticle phase is written as 
( )p p p p p fV v v f v Gvtρ μ∂⎛ ⎞+ ⋅∇ = − −⎜ ⎟∂⎝ ⎠  (5.4) 
where ρp is the density of the nanoparticle, f is the drag constant, and G is the lag 
coefficient(Anderson et al., 1974). In general, f depends on the size and geometry of the 
nanoparticle. G depends on the size and geometry of the nanoparticle as well as the pore size and 
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 geometry of the medium. Equations (5.1)-(5.4) have explicitly included terms representing 
hydrodynamic interactions between the nanoparticles, the carrying fluid, and the porous medium. 
To get an analytical solution, we introduce two approximations: inertia-free 
approximation and dilute-suspension approximation. The first approximation allows us to set ρf 
and ρp to be zero and the second approximation allows us to set nVp to be zero. Equations (5.1)-
(5.4) are simplified to 
0fv∇⋅ =  (5.5) 
( ) 0pnR nvt∂ + ∇ ⋅ =∂  (5.6) 
fp v
φμ
κ∇ = −  (5.7) 
pv Gv= f  (5.8) 
The fluid mechanics part and the mass transfer part of the problem get decoupled thanks to the 
above-mentioned approximations. The fluid mechanics part can be determined by solving 
equations (5.5), (5.7), and (5.8) simultaneously. The mass transfer part can be determined by 
solving equation (5.6) with the solution of the fluid mechanics part. Note that there are no time 
derivatives in equations (5.5), (5.7) and (5.8). Therefore the solutions for p, vf and vp will be 
steady-state if the boundary conditions are time-independent. We examine two kinds of time-
independent boundary conditions in detail (Basser 1992). 
 
① Infusion from a constant pressure source 
In this case, it is assumed that fluid is infused into the porous medium through a spherical cavity 
of radius b which is maintained at a constant pressure P0. 
Since the boundary condition is time-independent, equation (5.5) can be simplified to 
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 ( )221 0f rd r vr dr =  (5.9) 
Integrating once, we get 
2f r
Av
r
=  (5.10) 
where A is an unknown constant. With vfr given by equation (5.10), the r component of equation 
(5.7) can be integrated, 
Ap B
r
φμ
κ= ⋅ +  (5.11) 
where B is an unknown constant. 
One of the boundary conditions for p is that p should vanish at infinity. Therefore 
Ap
r
φμ
κ= ⋅  (5.12) 
The other boundary condition,  p = P0 at r = b, sets the integration constant A to be 
0bPA κφμ=  (5.13) 
Therefore 
0
2f r
bPv
r
κ
φμ=  (5.14) 
Equation (5.8) tells us that 
0
2pr
G bPv
r
κ
φμ=  (5.15) 
Plug equation (5.15) into equation (5.6), 
0
2 0
n G bP n
t R r r
κ
φμ
∂ ∂+ ⋅∂ ∂ =  (5.16) 
The initial and boundary conditions for n are 
At t = 0, n = 0; at r = b, n = n0; at r , n = 0. →∞
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 The solution is 
1
3
30
0
1
3
30
3  if 
30    if 
G bP tn b r b
R
n
G bP tr b
R
κ
φμ
κ
φμ
⎧ ⎛ ⎞≤ ≤ +⎪ ⎜ ⎟⎝ ⎠⎪= ⎨⎪ ⎛ ⎞> +⎪ ⎜ ⎟⎝ ⎠⎩
 (5.17) 
② Infusion from a constant flow source 
In this case, it is assumed that fluid is infused from a constant flow source Q0. 
Again, we have equation (5.10), with the integration constant A to be determined by the 
following boundary condition, 
0 f
r b
Q vφ
=
= ∫∫    dS  (5.18) 
Note that equation (5.18) is consistent with our dilute-suspension approximation. 
A is found to be 
0
4
QA πφ=  (5.19) 
Therefore 
0
24f r
Qv
rπφ=  (5.20) 
Equation (5.8) tells us that 
0
24pr
GQv
rπφ=  (5.21) 
Plug equation (5.21) into equation (5.6), 
0
2 04
n GQ n
t R r rπ φ
∂ ∂+ ⋅∂ ∂ =  (5.22) 
The initial and boundary conditions for n are 
At t = 0, n = 0; at r = b, n = n0; at r , n = 0. →∞
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 The solution is 
1
3
30
0
1
3
30
3  if 
4
30    if 
4
GQ tn b r b
R
n
GQ tr b
R
π φ
π φ
⎧ ⎛ ⎞≤ ≤ +⎪ ⎜ ⎟⎝ ⎠⎪= ⎨⎪ ⎛ ⎞> +⎪ ⎜ ⎟⎝ ⎠⎩
 (5.23) 
It can be shown that the two kinds of boundary conditions discussed above are equivalent to each 
other with 0 0 / 4P Q bμ πκ= . 
 
5.3  Results and Discussion 
 
Since constant flow rate infusion is equivalent to constant pressure infusion, we only 
discuss constant flow rate infusion. According to equation (5.23), the nanoparticle number 
density profile at any given time is step-like. There is a clear boundary beyond which the 
nanoparticle number density is zero and within which the distribution is uniform. The moving 
wave front has an explicit expression as 
1
3
303
4
GQ t b
Rπ φ
⎛ ⎞+⎜⎝ ⎠⎟  and the corresponding volume of distribution Vd is 
304 3
3 4
GQ t b
R
π π φ
⎛ ⎞+⎜ ⎟⎝ ⎠ . 
In typical convection enhanced delivery experiments, b is very small and can be 
neglected. Vd is simplified to 0
GQ t
Rφ . If we define the volume of infusion Vi as , 0Q t
then  
d
GV
R i
Vφ=  (5.24) 
This equation indicates that the volume of distribution Vd is directly proportional to the lag 
coefficient G and inversely proportional to the retardation factor R. If the particles have 
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 unrestricted mobility, i.e. the particles are small enough to behave as tracers in the fluid, then 
both G and R are unity. /d iV V φ= , which is a well-known relation for free-moving small 
molecules. If the particles are subject to linear bindings, then 1 0 21 /b bR k B k= + , where B0 is the 
concentration of binding sites and  is the affinity constant on an extracellular space basis 
(Morrison et al., 1994). In this case, R is greater than one and the wave front of the particle 
distribution is retarded. The value of R reflects surface properties of the particles and non-
hydrodynamic interactions between the particles and the medium. We further assume that R has 
a functional dependence on the particle radius a (assuming spherical shape) by 
1 /b bk k 2
21 sR c a= +
2 2/ 3 ta
2 2
0/ 3a R
, 
where cs is a constant. This means that we assume that the retardation effect R-1 is proportional 
to the surface area of the particle. The proportionality constant cs depends on the surface 
properties of both the particles and the medium. The lag coefficients have been studied in detail 
for several situations (Happel et al., 1973). For a sphere with radius a moving in the center of a 
circular cylindrical tube with radius at, the lag coefficient G is given by 1 2 . It is 
interesting to notice that a sphere whose radius is as large as that of the tube could still have a 
non-zero lag coefficient of 1/3. In the context of our theory, G is given by 1 2 , where R0 
is the equivalent radius of the micro-channel in the porous medium. Plugging the expressions for 
the retardation factor R and the lag coefficient G into equation (5.24), we get 
a−
−
2
2
0
2
21
3
1
i
d
s
a
VRV
c a φ
−
= + ⋅  (5.25) 
This equation indicates that the volume of distribution Vd has a complicated functional 
dependence on the particle radius a. 
We compare our mathematical model with some experimental results conducted on brain 
tissues. Chen et al. (2005) investigated the influence of sizes and surface properties of infused 
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 nanoparticles on their distributions within the brain by convection enhanced delivery. It was 
found that surface properties as well as sizes could significantly alter nanoparticle distributions. 
A prominent example is that bovine serum albumin (BSA) coating on the infused nanoparticles 
can greatly enhance the distribution by preventing hydrophobic interactions between the particles 
and the extracellular matrix. The fact that BSA, a 7-nm-diameter macromolecule, can be freely 
distributed in the extracellular space is reflected in the satisfaction of the relation /d iV V φ= . 
These facts indicate that BSA is an ideal coating and, to a first approximation, nanoparticles 
coated with BSA can be assumed to have unity retardation factors (i.e. no surface interactions). 
Setting cs to be zero in equation (5.25), we have 
2
2
0
21
3
i
d
a VV
R φ
⎛ ⎞= − ⋅⎜ ⎟⎝ ⎠
 (5.26) 
 
Figure 5.1: Plot of volume of distribution Vd as a function of nanoparticle radius a using equation 
(5.26). Nanoparicles are coated with BSA. 
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Figure 5.2: Plot of volume of distribution Vd as a function of nanoparticle radius a using equation 
(5.25). Nanoparicles are coated with BSA. 
 
 
Figure 5.3: Plot of volume of distribution Vd as a function of nanoparticle radius a using equation 
(5.25). Nanoparicles are not coated with BSA. 
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Figure 5.4: Plot of volume of distribution Vd as a function of nanoparticle radius a using equation 
(5.25) with three different cs values. 
Equation (5.26) is applicable to BSA coated nanoparticles. This equation indicates that the 
volume of distribution Vd has a quadratic dependence on the nanoparticle radius a. The porosity 
φ  is taken to be 0.2. R0 was estimated to be 38-64 nm by previous experiments (Throne et al., 
2006) and is set to be 51 nm in the following calculations. Figure 5.1 shows the correlation 
between particle size and volume of distribution of nanoparticles with BSA coating. Dots 
represent experimental data while lines represent predictions from equation (5.26). Note that 
there are no free fitting parameters involved in the predictions from equation (5.26). Thus, it is 
not surprising that the results only show limited success. If we assume that there are still residual 
surface interactions even after coating the nanoparticles with BSA, we need to use equation 
(5.25) with a non-zero cs. Figure 5.2 shows the correlation by introducing the free fitting 
parameter cs appearing in equation (5.25). We get cs = 4.0×10-3 nm-2 for nanoparticles with BSA 
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 coating. The general trend exhibited by the experimental data is able to be reproduced in Figure 
5.2. For nanoparticles without BSA coating, surface interactions are significant and the 
retardation factors are not unity. Figure 5.3 shows fitting of the experimental data to equation 
(5.25). We get cs = 1.5×10-2 nm-2 for nanoparticles without BSA coating. Again, the general 
trend exhibited by the experimental data is able to be reproduced. The value of cs for 
nanoparticles with BSA coating is four times larger than nanoparticles without BSA coating. For 
comparison, Figure 5.4 plots three curves generated from equation (5.25) with cs = 0, 4.0×10-3, 
and 1.5×10-2 nm-2, respectively. The three curves converge as the nanoparticle radius approaches 
zero. As we can see, both the surface properties and sizes of the nanoparticles can significantly 
affect their volumes of distribution. 
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 CHAPTER 6 
 
MODELING OF CEREBRAL MICROHEMORRHAGE 
 
6.1  Introduction 
 
It is estimated that 780,000 strokes occur in the United States every year. Stroke is the 
leading cause of adult disability in the United States and is the number two cause of death 
(Feigin et al., 2005). There are two types of strokes: ischemic and hemorrhagic. Thirteen percent 
of stroke cases are hemorrhagic. Cerebral hemorrhages account for 30–60% of hospital 
admissions for stroke (Yadav et al., 2007). A cerebral hemorrhage is an intra-axial hemorrhage; 
that is, it occurs within the brain tissue rather than outside of it. It has a high mortality rate. 
Besides, recent evidence has suggested a link between microhemorrhage and cognitive decline in 
humans (Haller et al., 2010). 
The physiological impacts due to microhemorrhages have been studied in animal models 
using pigs, rabbits, dogs, cats, and rodents. The bleed is usually created in the striatum, but other 
regions have been targeted. The most commonly used methods are intraparenchymal infusion of 
either autologous blood (Bullock et al., 1984) or bacterial collagenase (Rosenberg et al., 1990). 
Both have achieved successes in identifying injury mechanisms and evaluating potential 
treatments (MacLellan et al., 2010). Spontaneous hemorrhagic strokes in hypertensive mice have 
also been studied (Iida et al., 2005) and it is found that the type and locations of stroke are 
reasonably similar to those observed in patients with hypertension. These microhemorrhages in 
animal models are difficult to control and often result in large regions of pathology, making it 
hard to observe the hemorrhage dynamics and the physiology immediately after the injury. 
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 A modern non-invasive, non-ionizing technique to visualize detailed brain structures is 
magnetic resonance imaging (MRI) (Filler, 2010). MRI techniques have been providing new 
insights into the pathophysiology and diagnosis of cerebral hemorrhage. Gradient-echo (GE) or 
T2*-weighted MRI is highly sensitive in the detection of old and recent cerebral hemorrhage 
(Fazekas et al., 1999; Offenbacher et al., 1996). GE MRI is capable of detecting millimeter-sized 
paramagnetic blood products in brain parenchyma (Atlas et al., 1988). With this technique, the 
number of visible hemorrhagic brain lesions has been considerably increased. 
Recent developments in optical techniques have enabled the application of an injury to a 
single segment of arteriole, capillary, or venule (Nishimura et al., 2007). A tightly-focused 
femtosecond laser pulse is used to disrupt the endothelial cells that line a specifically targeted 
vessel. The technique allows any blood vessel in the top 0.5 mm of the cortex of a rodent to be 
selectively lesioned. This method along with two-photon excited fluorescence (2PEF) allows the 
observation of the pathophysiology after the microvascular injury with high temporal and spatial 
resolutions. 
In this chapter, we present mathematical models, derived from both fundamental 
considerations and empirical correlations, to describe the statics and the dynamics in cerebral 
microhemorrhage and compare the models with the experimental data.  
 
6.2  Mathematical Model  
 
To better understand the mathematical models introduced below, we first give a short 
description of the experimental procedures used to collect the data. Adult mice were used in the 
experiments to characterize hemorrhage dynamics and tissue compression. Before laser ablation 
and imaging, mice were anesthetized on isoflurane and were intravenously injected with Texas-
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 Red dextran fluorescent dye to label the blood plasma. Microhemorrhages were induced by 
focusing femtosecond laser pulses on the wall of the targeted penetrating arterioles (PA). 2PEF 
movies of the microhemorrhage process were captured. During the microhemorrhage, red blood 
cells (RBCs) and plasma exit the lumen of the targeted PA. The RBCs are visualized as dark 
patches in a sea of fluorescently-labeled plasma. Our goal is to develop mathematical models to 
describe the statics and dynamics of microhemorrhage. Unfortunately, we have not yet found a 
unified theoretical approach to deal with both the statics and the dynamics. In the following, a 
poroelastic model is used to describe the statics and a semi-empirical model is used to describe 
the dynamics. 
 
6.2.1  Microhemorrhage Statics 
 
We treat brain tissue as a fluid-saturated poroelastic network (Basser, P., 1992; Edelman, 
I.Y., 1999; Netti et al., 1997). 
Stress-strain relations for the fluid phase is written as 
f fp Iσ = −  (6.1) 
where fp  is the pressure in the fluid phase, and I  is the unit tensor. 
Stress-strain relations for the solid phase is written as 
( )2s s sG Trσ ε λ ε= + I  (6.2) 
where G and λ  are Lame constants for the solid phase. 
The strain tensor sε  is the symmetric part of the gradient of the displacement vector su  of the 
solid phase, 
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 ( )12 Ts s su uε ⎡ ⎤= ∇ + ∇⎢ ⎥⎣ ⎦  (6.3) 
where T is the transpose operation. 
At mechanical equilibrium, the divergence of the total stress is zero, 
( ) ( ){ }1 2 s s fG Tr I p Iφ ε λ ε φ⎡ ⎤∇ ⋅ − + − =⎢ ⎥⎣ ⎦ 0  (6.4) 
where φ  is the porosity. 
Substituting equation (6.1) into equation (6.4), we obtain Navier’s equation, 
( ) (21f s )sp G u G uφ λφ− ⎡ ⎤∇ = ∇ + + ∇ ∇⋅⎣ ⎦  (6.5) 
At mechanical equilibrium, we also have 0fp∇ = . Thus 
( ) ( )2 0s sG u G uλ∇ + + ∇ ∇ ⋅ =  (6.6) 
Assuming spherical symmetry, the r component of equation (6.6) is written as 
( ) ( )2 22 2 21 2 1 0sr sr srd du u d dG r G r ur dr dr r dr r drλ⎡ ⎤⎛ ⎞ ⎛ ⎞− + + =⎜ ⎟ ⎜ ⎟⎢ ⎥⎝ ⎠ ⎝ ⎠⎣ ⎦  (6.7) 
After some straightforward algebra, equation (6.7) is simplified to 
( )221 0srd d r udr r dr⎛ ⎞ =⎜ ⎟⎝ ⎠  (6.8) 
Integrating equation (6.8) twice, we get 
23sr
Ar Bu
r
= +  (6.9) 
where A and B are unknown integration constants. 
We know that as r approaches infinity, usr should be finite. This means A = 0. Equation (6.9) is 
simplified to 
2sr
Bu
r
=  (6.10) 
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 To figure out B, we need to apply the boundary condition at r = aRBC, where aRBC is the steady 
state radius of the cavity filled with RBCs after the microvascular injury. 
( ) 22
RBC
sr sr
c
r a
du uG
dr r
λ λ τ
=
⎡ ⎤+ + =⎢ ⎥⎣ ⎦ −  (6.11) 
where τc is the contact stress at the boundary between the surrounding tissue and the RBC core. 
This boundary condition leads to 
3
4
RBC caB
G
τ=  (6.12) 
The final expression for usr as a function of r is 
3
24
RBC c
sr
au
Gr
τ=  (6.13) 
or 
2
4
sr c
RBCRBC
u r
G aa
τ ⎛ ⎞= ⎜⎝ ⎠⎟  (6.14) 
When equation (6.14) is fitted with experimental data, τc can be extracted. 
 
6.2.2 Microhemorrhage Dynamics 
 
Let us take a look at a very thin layer of solid materials right at the boundary between the 
RBC core and the surrounding tissue. Assume the mass of such a thin slice is m. When the cavity 
expands, two forces in opposite directions are exerted upon m. The force pointing outward is the 
stress exerted by the closely packed RBCs in the cavity. The more RBCs present in the cavity, 
the larger this force is. Thus we assume that at any given moment this force is proportional to the 
radius of the RBC cavity aRBC(t) with a proportionality constant of kR. The force pointing inward 
is the stress exerted by the surrounding tissue. We can think the surrounding tissue as a reservoir 
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 for stress releasing and treat the inward-pointing force as a constant Ft. With these two forces, 
we can write down the equation of motion for m along the radial direction, 
( ) ( )2 2RBC R RBC td a tm k a tdt = − F  (6.15) 
The general solution is  
( ) R Rk kt ts mRBC
R
Fa t Ce De
k
−= + + m  (6.16) 
where C and D are unknown integration constants. 
As t goes to infinity (steady state), R should be finite. This means C = 0. 
( ) Rk ts mRBC
R
Fa t De
k
−= +  (6.17) 
( )0RBCa = 0  gives t
R
FD
k
= − . 
Thus 
( ) 1 Rk tt mRBC
R
Fa t e
k
−⎛ ⎞= −⎜ ⎟⎜ ⎟⎝ ⎠
 (6.18) 
Equation (6.18) can be written as 
( ) 1 tRBC RBCa t a e τ−⎛ ⎞= −⎜⎝ ⎠⎟  (6.19) 
where  and τ are constants independent of time. RBCa
When equation (6.19) is fitted with experimental data,  and τ can be extracted. RBCa
To derive an expression for aplasma(t), the distance from the center to the edge of the plasma 
perfusion, we assume that the infusion of plasma to the surrounding tissue is of constant 
volumetric flow rate Q. Mass conservation requires that 
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 ( ) ( )3 34
3 plasma RBC
a t a t Qπ φ⎡ ⎤− ⋅ =⎣ ⎦ t⋅  (6.20) 
When equation (6.20) is fitted with experimental data, Q can be extracted. 
 
6.3  Results and Discussion 
 
The extravasated RBCs are mainly responsible for displacing nearby cellular structures.  
From experimental measurement and image analysis, the magnitude and direction of dendrite 
displacement vectors after a microhemorrhage can be obtained. The distribution of the 
displacement vectors confirms the spherical symmetry assumption and the 1/r2 decay of the 
compression. From the compression magnitudes averaged over all mice, we are able to extract 
the contact stress between the RBC core and the surrounding tissue by fitting the data to equation 
(6.14) (Figure 6.1).  
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Figure 6.1: Distribution of the displacement magnitude. Dots represent the experimental data and 
solid line represents the fitted curve. 
 
 
Figure 6.2: Relaxation dynamics of the RBC core. Dots represent the experimental data and solid 
line represents the fitted curve. 
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Table 6.1: τ and aRBC fitted by equation (6.19). 
Mouse number τ / s aRBC / μm  
1 0.25 48 
2 1.5 39 
3 0.43 35 
4 0.36 44 
5 0.64 72 
6 0.50 72 
7 0.30 56 
8 1.2 21 
9 1.9 23 
10 1.3 53 
11 0.33 29 
12 0.71 29 
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 Table 6.2: Q fitted by equation (6.20). 
Mouse number Q / (μL/min) 
1 48.4 10−×  
2 43.3 10−×  
3 31.3 10−×  
4 46.9 10−×  
5 N/A 
6 21.4 10−×  
7 27.3 10−×  
8 54.9 10−×  
9 N/A 
10 36.6 10−×  
11 31.3 10−×  
12 31.3 10−×  
 
With a G value of 2 kPa (Basser, 1992), the contact stress at the interface is calculated to be ca. 2 
kPa. This is significantly smaller than the arteriole intraluminal pressure, which has been found 
to be 8 kPa (Driessen et al., 1982). Although this value was measured in rat mesentery, which 
may differ from that in mice brain, it has been observed experimentally that almost all of the 
capillary segments are preserved post-hemorrhagically in the vicinity of the injury. This indicates 
that the compressive stress due to a microhemorrhage is not high enough to produce a disaster of 
capillary collapse, which may lead to ischemia, cellular dysfunction, or death. 
Immediately after laser ablation, the RBCs and the plasma flush out into the extracellular 
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 matrix and form a small cavity in no more than several seconds. The RBCs inside the cavity 
serve as a support for the cavity against adjacent tissue. The plasma perfuses through the 
interstitial space and penetrates into the surrounding tissue. Equation (6.19) is used to extract the 
relaxation time constant τ (Table 6.1). There is a great variation in τ, ranging from 0.2 s to 2 s. It 
seems that there are no correlations between τ and aRBC. The average τ value from all mice is 0.8 
s. Figure 6.2 shows typical relaxation dynamics of the RBC core. Equation (6.20) is used to 
extract the plasma perfusion flow rate Q (Table 6.2). There is a great variation in Q, with the 
highest value being three orders of magnitude larger than the lowest value. It seems that there are 
no correlations of Q with either τ or aRBC. 
As we can see, the mathematical model developed here to describe the microhemorrhage 
dynamics is rather simple and heuristic. It is highly desirable that we have a unified theory to 
describe both the statics and the dynamics. As in the model for the statics, we have made several 
attempts to develop a model for the dynamics based on the theory of fluid-saturated poroelastic 
network. Unfortunately, those attempts were not successful. We encountered a major difficulty 
in the mathematical derivations. The boundary between the RBC core and the surrounding tissue 
is moving all the time. A moving boundary, seemingly not problematic, often requires the help of 
complicated computer algorithms. We hope that our heuristic model for the dynamics could at 
least provide some useful information for the biomedical community. 
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 CHAPTER 7 
 
DESIGN AND FABRICATION OF MICROFLUIDIC PROBES WITH INTEGRATED 
PRESSURE SENSORS FOR CONVECTION ENHANCED DRUG DELIVERY 
 
7.1  Introduction 
 
Convection-enhanced delivery (CED) has proven to be a promising new technique for 
treating neurological disorders. Many compounds have been delivered in both animal and human 
experiments using CED. For example, small molecules (Bobo et al., 1994; Groothuis et al., 1999; 
Lonser et al., 1999), proteins (Laske et al., 1997; Lieberman et al., 1995; Lonser et al., 2002), 
growth factors (Hamilton et al., 2001; Yang et al., 2002), and nucleotides (Groothuis et al., 2000) 
have been examined in animals. Chemotherapy drugs (Lidar et al., 2004; Mardor et al., 2001), 
proteins (Kunwar et al., 2007; Sampson et al., 2003; Weber et al., 2003), and viral vectors (Ren 
et al., 2003; Worgall et al., 2008) have been examined in human clinical trials. In CED, a small 
catheter or needle is inserted into an afflicted region and drug-containing solutions are directly 
infused into that region at a specified flow rate. This technique circumvents the blood brain 
barrier (BBB). Compared to systemic delivery, higher local concentrations of therapeutic agents 
can be achieved with fewer side effects. Because many drugs delivered directly to the brain are 
subject to rapid clearance from the extracellular space (Haller et al., 1998), drugs delivered by 
diffusion from polymeric implants or bolus injections are only able to penetrate a small distance 
into the tissue. Unlike diffusion, which relies on a concentration gradient, CED relies on the bulk 
flow to carry compounds through the extracellular space. As a result, drugs can penetrate into the 
tissue that is much further from the delivery site. 
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 In most prior studies on CED, stainless steel needles were often used and ranged from 20 
to 32 gauge in size. Flow rates were controlled with an external syringe pump and ranged from 
0.1-10 μL/min. Operation with known flow rates has the benefit of better control of the delivered 
dose. At flow rates greater than 1 μL/min, backflow of infused solution up to the outside of the 
needle shaft has been reported (Chen et al., 1999). This is an eminent and long-existing problem 
associated with CED. Brain tissue is a poroelastic medium. Since there is usually no contact 
stress between the infusion needle and the tissue at the infusion point, the adjacent tissue is free 
to move away from the needle during infusion. This movement of the tissue is the cause of reflux 
of infused solution along the needle-tissue interface and the phenomena is called backflow. This 
is the cause of many treatment induced complications in CED. Backflow leads to poor control 
over the fate of infused drugs which often end up in healthy tissue. The separation between the 
needle and the adjacent tissue that allows backflow to happen can be controlled by adjusting the 
flow rate and the size of the needle (Morrison et al., 1999). Another problem associated with 
CED is that it is possible that the outlet of needle is partially or fully occluded after it is inserted 
into the brain. It has been suggested that a needle with fluid outlets along its side, rather than at 
its tip, could avoid or alleviate the occlusion problem (Chen et al., 2004).  
Microfabricated probes offer several potential advantages over traditional needles used in 
CED. A microfabricated probe can be made small to minimize tissue damage (Zahn et al., 2000), 
reduce backflow (Neeves et al., 2006), yet rigid enough to penetrate deep into tissue. The fluid 
outlet can be located away from the penetrating edge of the probe to avoid occlusion of the 
channel. Furthermore, microfabrication offers the possibility of integrating electrical, 
mechanical, and chemical sensors with the fluid delivery system (Chen et al., 1997; Retterer et 
al., 2004; Zahn et al., 2000). 
For CED, an integrated pressure sensor is desirable since pressure drops are often good 
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 indicators of serious backflow problems or other failures. Capacitive pressure sensors fabricated 
by multilayer parylene/photoresist techniques have been demonstrated on whole silicon wafers 
(Shih et al., 2003). The goal of this chapter is to describe the design and fabrication of a 
microfluidic probe with a capacitive pressure sensor integrated at its tip. Such a device should be 
able to monitor the tip pressure rather than an upstream pressure because, more often than not, it 
is desirable that the pressure reading only reflects flow through the tissue rather than flow 
through the syringe, needle, and tissue. 
 
7.2  Experimental Design 
 
The microfluidic probe consists of three parts: an insertable microprobe, a handle, and a 
protrusion to be connected to external tubing (Neeves et al., 2006). 
Figure 7.1 shows a schematic of the device (not in scale). Red lines represent the profile of the 
probe, green lines represent the profile of the microfluidic channel, and yellow lines represent the 
profile of the electrodes. Figure 7.2 shows another schematic of the device (in scale). Figure 7.3 
shows a zoom-in view of the probe tip (in scale). The pressure sensing functionality is realized 
by creating a two-plate configuration of a capacitor (Figure 7.4). The upper electrode is 
sandwiched between two partially suspended parylene layers and the bottom electrode is fixed 
on the substrate. The microfluidic channel is on top of the upper electrode. When the local 
pressure in the microfluidic channel changes, the capacitance between the two electrodes will 
change. With proper device calibration, this capacitance change can be  
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Figure 7.1: Schematic of the probe (not in scale). Red lines represent the profile of the probe, 
green lines represent the profile of the microfluidic channel, and yellow lines represent the 
profile of the electrodes. 
 
 
Figure 7.2: Schematic of the probe (in scale). Red lines represent the profile of the probe, green 
lines represent the profile of the microfluidic channel, and yellow lines represent the profile of 
the electrodes. 
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Figure 7.3: Zoom-in view of the probe tip (in scale). 
 
used to calculate the corresponding pressure change. The air gap (the cavity between the two 
electrodes) is unsealed to maintain a constant atmospheric reference pressure. Other parts of the 
electrodes are designed for transductions of the electrical signals from the sensing areas to the 
bonding pads. The bonding pads (the big yellow polygonal parts of the electrodes, see Figure 
7.4) will be connected to a commercially available capacitance meter. 
The fabrication process is described as follows (Figure 7.4): To start the fabrication, a 
silicon dioxide etch mask is deposited using plasma enhanced chemical vapor deposition 
(PECVD) on the backside of a double-sided, polished silicon wafer with a thickness of 300 μm. 
The backside of the wafer is then etched with deep reactive ion etching (DRIE) to a depth of 200 
μm to define the insert and protrusion thickness. A 2 μm silicon dioxide layer is then deposited 
on the back side of the wafer using PECVD. This layer acts as an etch stop when the front side of 
the wafer is etched using DRIE in a subsequent step. To form a base layer and promote adhesion, 
a 1 μm thick layer of photo-sensitive polyimide is spun, patterned, and cured on the front side of 
the wafer. Next, a 10 nm layer of Cr and a 300 nm layer of Au is electron  
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Figure 7.4: Summary of fabrication process. (a) Backside oxide deposition and patterning, 
backside DRIE, backside oxide deposition for etch stop, polyimide deposition and patterning, 
Cr/Au deposition and patterning ,parylene deposition sacrificial photoresist spinning and 
patterning, parylene deposition, Cr/Au deposition and patterning, parylene deposition, sacrificial 
photoresist spinning and patterning, parylene deposition, Al deposition and patterning. (b) 
Patterning of parylene by oxygen plasma, DRIE of front side silicon. (c) Dissolution of Al, 
dissolution of oxide, release of sacrificial photoresist. 
 
beam evaporated and patterned in the shape of the bottom electrodes. The Cr layer acts as an 
adhesion layer for Au. A layer of parylene is then deposited to a thickness of 1 μm. Sacrificial 
photoresist is spun on top of the parylene to form a layer of height 4 μm. This sacrificial layer 
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 defines the capacitive air gap in the pressure sensor. After another 1 μm parylene layer, a second 
Cr/Au layer (10 nm / 150 nm) is deposited and patterned to produce the top electrodes of the 
pressure sensor and the parallel plate configuration. A third 1 μm layer of parylene is then 
deposited and a 10 μm sacrificial photoresist layer is deposited and patterned to define the 
microfluidic channel above the pressure sensor. A final 1 μm layer of parylene is then deposited. 
Next, a 150 nm thick Al etch mask is electron beam evaporated. This mask is patterned using 
wet etching. An oxygen reactive ion etching (RIE) is then used to etch through the parylene to 
the silicon wafer. This etching step defines the device body and opens the ends of the air gaps 
and the microfluidic channels. The silicon is etched down to the oxide etch stop using DRIE to 
define the insert and protrusion geometry. The oxide etch stop and Al mask are simultaneously 
removed in buffered oxide etch. Finally, the photoresist is removed from the air gaps and the 
microfluidic channels in an acetone bath. 
 
7.3  Results and Discussion 
 
Fabrication of the as-designed device has not been successfully completed. There are 
several difficulties and problems arising in the actual fabrication trials. First, the adhesion of 
parylene to the substrate is problematic. Prior to parylene deposition, the substrate needs to be 
treated by mild oxygen plasma and dehydrated either on a hot plate or in a convection oven. The 
as-deposited parylene film is able to adhere well on the substrate. Yet the bond is weak and the 
film tends to peel off in subsequent processing steps, especially those steps involving wet 
chemicals. Second, the patterning of the upper electrodes is problematic. The bottom electrodes 
have been successfully patterned using lift-off techniques. Due to the presence of the first 
sacrificial photoresist layer which is intended to form the air gap upon dissolution, part of the 
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 connections between the top electrodes and the bonding pads resides on the tilted part of the 
parylene layer covering the sidewall of the sacrificial photoresist. As a result, the top electrodes 
have to be patterned by wet etching instead of lift-off. It is difficult to control the etching of the 
Cr layer due to its thickness. Third, the environment in which parylene is deposited is 
problematic. The fabrication process was carried out in the Cornell NanoScale Science & 
Technology Facility (CNF). Its parylene deposition system is located in a normal laboratory 
rather than in a cleanroom. Dust particles falling onto the surface of the wafer are of serious 
problems. They are hard to get rid of and they introduce an exponentially-growing number of 
defects in later processing steps. There are a total of 4 layers of parylene to be deposited. Each 
time the wafer has to be exposed to a non-cleanroom environment. And there are quite many 
processing steps between and after parylene depositions. This introduces lots of defects on the 
surface of the wafer. Before devices can be successfully fabricated, all these problems need to be 
resolved. 
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 CHAPTER 8 
 
MICROMACHINED DISSOLVED OXYGEN SENSOR BASED ON SOLID POLYMER 
ELECTROLYTE 
 
8.1  Introduction 
 
Dissolved oxygen sensors are important for measuring the oxygen content in body fluids 
and tissues (Baumgartl et al., 1983; Althoff et al., 1985) and can be used as basic devices for 
integrated biosensor applications (Nanjo et al., 1974; Mascini et al., 1986; McKean et al., 1988). 
Dissolved oxygen sensors presently available on the market are relatively large devices that are 
difficult to use in some biological and biomedical applications. The devices often require labor-
intensive manufacturing and assembly owing to the complicated and delicate structures 
embedded in them. Microfabrication technology such as photolithography provides the 
possibility of easy and cost effective production of smaller devices while improving the usability 
and robustness of these devices. 
Miniaturization has been an important trend in the fabrication of sensors for the past four 
decades. For the specific case of dissolved oxygen sensors based on electrochemical methods, 
the immediate benefits from miniaturization are little oxygen consumption and enhanced spatial 
resolution. One of the earliest versions of miniaturized dissolved oxygen sensors was fabricated 
from glass micropipettes. For example, in the work by Whalen et al. (1967), a glass capillary 
tube was drawn out in a pipette puller and filled almost to the tip with molten metal. The metal in 
the recess was subsequently plated with gold and the recess filled with collodion. The sharp 
microelectrode had a long, tapering point, with a tip of 1-2 μm. The sharp tip could be utilized to 
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 impale cells in intracellular oxygen level measurements. These types of microsensors had to be 
manually fabricated and assembled one by one. In the past three decades, owing to the progress 
in semiconductor and micromachining techniques, various types of miniature oxygen sensors 
have been proposed (Koudelda, 1986; Suzuki, et al., 1988, 1990, 1991, 1993, 1998, 2000, 2001; 
Wu et al., 2005; Jobst et al., 1993; Yang et al., 1997). The majority of these sensors were Clark-
type. The Clark-type sensor operates by electrochemically reducing the dissolved oxygen in 
solution and measuring the electrical current to determine the oxygen level. The main advantage 
of the Clark-type design is that all the electrodes required for operation are contained within an 
inert gas permeable membrane. This membrane allows the device to be used in delicate 
biological media such as blood. Isolating the electrodes from the media improves the accuracy of 
the measurement, since it eliminates other electroactive species from giving additional reduction 
current signals. In the three-electrode configuration, the construction of the working, reference, 
and counter electrodes could be easily integrated by micromachining techniques. It was also 
possible to incorporate on-chip microstructures, on-chip electronic circuits, and other chemical 
microsensors (e.g. glucose sensors) into the fabrication process. Clark-type oxygen sensors 
require a compartment filled by aqueous electrolyte between the membrane and the electrode. 
This requirement has dramatically complicated the fabrication procedure, decreased the 
robustness of the device, and lead to the need for rehydration in long term storage. Hydrogel and 
solid polymer electrolyte have been shown to be able to replace the aqueous-electrolyte-filled 
compartment. Among these methods, the PCM approach is especially attractive due to the 
simplicity and scalability of the fabrication and packaging procedures (McLaughlin et al., 2002). 
However, there are some common shortcomings from an industrial and medical point of view in 
most of the previous work on miniature oxygen sensors constructed by micromachining 
techniques: First, the fabrication procedures are lengthy and time-consuming, making these 
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 devices inamicable for large-volume production and thus not disposable. Second, the materials 
used for the working, reference, and counter electrodes in these devices are different. This means 
that the thin films used as the working, reference, and counter electrodes have to be deposited 
and patterned one by one, which greatly complicates the processing procedures. Third, none of 
them is well transferable for clinical applications. The functional parts of these sensors are small, 
but the whole sensors are big and therefore non-implantable. In this paper, we describe an 
extremely simple monolithic procedure for fabricating and packaging disposable, dissolved, 
PCM-based oxygen sensors that are suitable for medical applications. We test these devices in 
PBS and BBS and evaluate their performances in terms of long term stability, reliability, 
hysteresis, linearity, sensitivity, and device-to-device variation, with a focus on medical 
usefulness. 
 
8.2  Experimental Methods 
  
8.2.1  Preparation of Microelectrode Probes 
 
Microelectrode probes were fabricated using standard micromachining techniques. A 
schematic of the electrode fabrication process is presented in Figure 8.1. To start the fabrication, 
a 500 nm insulation layer of silicon dioxide was deposited on a 4-inch silicon wafer (500 μm 
thick, single side polished, <100> crystal orientation) by plasma enhanced chemical vapor 
deposition (PECVD) (GSI single wafer PECVD, GSI Group Sciences) The lift-off technique was 
used to define the electrode geometry (Figure 8.2 and 8.3). The geometry and arrangement of the 
three electrodes are similar to those in ref. 15. Layers of 30 nm of Ti and 130 nm of Pt were 
electron beam evaporated (CHA Mark 50 e-Beam Evaporator) on the substrate to form the 
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 electrodes.  
 
Figure 8.1: Summary of photolithographic processes. (a) Deposition of silicon dioxide insulation 
layer, (b) Deposition and patterning of platinum metallization layer, (c) Deposition and 
patterning of silicon nitride capping layer. 
 
 
 
Figure 8.2: Schematic illustration of the device planar structure (not in scale). 
 
92 
  
 
Figure 8.3: Schematic illustration of the electrode configuration (not in scale). 
 
Wafers were then coated with a 400 nm capping layer of low stress silicon nitride by PECVD. 
The recording areas and the bonding pads were defined by selectively etching the silicon nitride 
layer using reactive ions (Oxford 81 Etcher, Oxford PlasmaLab 80+ RIE System). Wafers were 
diced into 1.1 mm×7.3 mm chips (Kulicke & Soffa 7100 Dicing Saw). For each chip, bonding 
pads were connected to insulated fine wires by silver conductive epoxy (MG Chemicals) and 
then insulated from the environment with regular epoxy (Epoxy 907, Miller-Stephenson). The 
exposed area of the working electrode was designed to be ca. 0.43 mm2. The areas of the 
working, reference, and counter electrodes are maintained in the ratios 1:0.2:0.44. The gap 
between the working electrode and the reference electrode is 15 μm and the gap between the 
reference electrode and the counter electrode is 60 μm. 
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 8.2.2  PCM Coating 
 
After fabrication and packaging, the microprobes were immersed sequentially in 
isopropyl alcohol, dilute sulfuric acid, and deionized water, each for 10 min, and then dried by a 
nitrogen gun. At this point, the microprobe was ready for deposition of the PCM. The PCM is a 
mixture of 5 wt.% solution of NafionTM, a perfluorinated ion-exchange resin (hydrogen ion 
form), in a mixture of lower aliphatic alcohols and water (Aldrich, Milwaukee, WI, USA) and 
polyvinylpyrrolidone (PVP-360) (Sigma, St. Louis, MO, USA) with 3 wt.% 2,6-
bis(azidobenzylidene)-4-methylcyclohexanone (Aldrich) in a ratio of 4:1. The NafionTM 
component provides ionic (proton) conductivity while the PVP-360 improves adhesion of the 
PCM to the substrate. 
For better adhesion, the device was dipped in a mixture of Silane 174A (Sigma) and 
ethanol in a ratio of 1:50 for 5 min and allowed to dry at 60 ℃ for 5 min. Next, the PCM was 
applied by either drop casting or dipping coating. In dipping coating, the device was dipped in 
the PCM solution for 5 min. In drop casting, 0.4 μL of PCM solution was applied to the surface 
of the device (area uncovered by epoxy, dimension 1.1 mm×1.5 mm) via a micropipette. Finally, 
the device was allowed to dry at 60 ℃ for at least 24 h. 
 
8.2.3  PCM Surface Morphology and Film Thickness Characterization 
 
Atomic force microscopy (AFM) was utilized to characterize the surface of the PCM. 
AFM was conducted on a Veeco Dimension 3100 Ambient AFM system employing an Olympus 
cantilever. Potential step chronoamperometry (PSC) was performed to estimate the thickness of 
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 the PCM film. All electrochemical experiments in this work were carried out on a CHI600D 
electrochemical work station. The settings of the electrochemical recording system were such 
that cathodic currents were defined to be positive and anodic to be negative. 
 
8.2.4  Evaluation of Sensor Performances 
 
We investigated the characteristics of the oxygen electrodes by immersing the device in 
either PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 10 mM KH2PO4, pH 7.4, EMD 
Chemicals, Inc.) or BBS (Rockland), allowing them to equilibrate, and monitoring their response 
by CV or LSV techniques. We reduced the oxygen concentration in the solution by means of 
purging the solution with pure nitrogen (high purity, Airgas). The output of the oxygen electrode 
was calibrated with a commercial dissolved oxygen meter (InO2, Innovative Instruments, Inc.). 
Sodium lactate was purchased from Sigma-Aldrich. 
 
8.3  Results and Discussion 
 
The physical dimensions of the device have been designed to be small enough for 
medical implantation purposes but large enough to minimize internal electrical resistance. 
Micromachining techniques offer a unique opportunity for creating large amounts of identical 
devices from a single processing batch in a cost effective manner. In our design, a total of 287 
devices can be obtained from a single 4-inch silicon wafer. The monolithic procedure in thin film 
Pt electrode fabrication has greatly reduced the processing steps involved. Pt is a common 
material of choice for the working and the counter electrode in oxygen reduction. Pt has also 
been shown to be able to serve as the reference electrode under certain conditions (Kasem, 
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 2008). For oxygen reduction, we have found that Pt can be used as the reference electrode for 
sensing purposes. A single layer of PCM coating has also dramatically reduced processing steps 
and time. In this work, the PCM coating serves the dual purposes of acting as the ionic 
conductive electrolyte and the interfering molecule blocking membrane. The drop-casting or dip-
coating approach makes the processing very inexpensive. 
 
Figure 8.4: AFM image of the surface of the PCM. The dimensions of the image are 12 μm by 
12 μm. 
 
Only the PCM film prepared by drop-casting was investigated in detail. Although dip-
coating procedures are easier and faster to carry out and the devices do, to some extent, work 
well in terms of oxygen sensing, we have found that dip-coating processed devices are not as 
robust as drop-casting processed ones and this method may lead to early device failure in 
repetitive operations. When the chips with Silane 174A adhesion layers are dipped in the PCM 
coating solution, Silane 174A may be partially stripped, which will lead to inferior adhesion and 
earlier device failure. On the other hand, due to the extreme simplicity of dipping-coating 
procedure, it is desirable to pursue adhesion layer enhancement treatment in the future to make 
such devices more reliable. 
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 Figure 8.4 shows the AFM image taken on a 12 μm×12 μm site area of the PCM surface. 
Most area of the surface appears to be smooth and pin-hole free. According to the image 
statistics, the mean roughness of the PCM surface is ca. 4 nm. The surface tension of the coating  
 
Figure 8.5: Linear sweep voltammograms obtained in air-equilibrated DI water and oxygen-
depleted DI water. 
 
 
Figure 8.6: Current-time curves obtained in air-equilibrated DI water and oxygen-depleted DI 
water. 
 
solution leads to a smooth surface morphology upon drying. The needle or bump-like surface 
structures can be attributed to defects (e.g. tiny dust particles). 
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 The PCM coating should be thick enough to prevent interfering species (e.g. proteins) 
from reaching the Pt surface but also thin enough to minimize oxygen diffusion resistance. The 
thickness of the PCM film is difficult to be measured accurately. We choose to estimate this 
parameter in two different ways. Based on the non-volatile content of the PCM coating solution 
and the measurement of the solution-covered geometric area, we estimate that the thickness of 
the PCM film is 6.7±0.7 μm (The variance in film thickness is estimated based on the variance of 
the solution dispensing apparatus). A second way to estimate the film thickness is based on PSC 
technique. Prior to measurement, the electrodes were electrochemically stabilized in air-
equilibrated DI water by CV from 0 V to -0.6 V at 2 V/s for 5 min and then at 0.06 V/s for 1 h. 
LSV measurements were subsequently carried out from 0 V to -0.6 V at 0.06 V/s for air-
equilibrated DI water and oxygen-depleted DI water (Figure 8.5). The difference between the 
two curves is attributed to oxygen reduction. In PSC measurements, the potential was stepped 
from 0 V to -0.6 V instantaneously and the current was recorded with time (Figure 8.6). In order 
to single out the faradaic current corresponding to oxygen reduction, we subtract the current 
recorded in oxygen-depleted DI water from air-equilibrated DI water. The background current 
recorded in the absence of oxygen represents double-layer charging effects and other faradaic 
processes occurring on the electrode surface. The background-subtracted current is fitted 
according to equation (1.4) and (1.10) in McLaughlin et al. (2002). In this way, the thickness of 
the PCM film is estimated to be 5.0±1.4 μm (n=10). Since the film thickness determines the 
mass transfer resistance to oxygen diffusion, the dynamical response of the device can be 
affected by variation in film thickness. From the film thickness and the oxygen diffusion 
coefficient in the film, the diffusion time constant of the device is estimated to be ca. 0.15 s. 
According to PSC measurements, there is a 28% relative variation in film thickness. One 
possible method to reduce device-to-device variation is to use a controlled stencil placed on top 
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 of the electrode to carry out the PCM coating step. Alternatively, thin film coating techniques 
other than drop-casting can be explored as replacements. 
The device can be operated in two distinct ways to detect oxygen concentrations in the  
 
Figure 8.7: Cyclic voltammograms obtained in PBS during electrochemical stabilization. 
 
 
Figure 8.8: Cyclic voltammograms obtained in BBS during electrochemical stabilization. 
 
solution (Bard et al., 2001). In the first way, LSV is utilized to quantify the oxygen level: for a 
given sweep rate, the current sampled at a given potential should be proportional to the oxygen 
concentration. In the second way, PSC is utilized to quantify the oxygen level: for a given 
potential step, the current sampled at a given time should be proportional to the oxygen 
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 concentration. These theoretical relations are valid in both the mass transfer controlled regime 
and the kinetics controlled regime. Operation in the mass transfer controlled regime has the 
advantage of yielding larger signals. In principle, LSV and PSC techniques are equivalent to 
each other. Many commercial dissolved oxygen sensors are based on PSC technique. In practice, 
we have found that, for PCM-based dissolved oxygen sensors, LSV technique is a better choice 
in terms of enhancing single-device repeatability and reducing device-to-device variations 
(Similar observations were reported in McLaughlin et al. (2002)). 
 
Figure 8.9: Linear sweep voltammograms obtained in PBS and BBS. 
 
Prior to measurements, the electrodes were electrochemically stabilized in air-
equilibrated PBS or BBS by CV from 0 V to -0.6 V at 2 V/s for 5 min and then at 0.06 V/s for 1 
h. In Figure 8.7 and 8.8, some cycles in the cyclic voltammograms at 0.06 V/s for 1 h are shown. 
The electrochemical activity of the electrode can reach the steady state faster and diminishes less 
in PBS compared to in BBS. The cathodic current includes oxygen reduction at the Pt surface, 
double layer charging, and other parasitic reactions. 
After the electrochemical stabilization procedure, the electrodes were left in quiescence 
in the solution for 3 min. Then LSV curves were recorded from 0 V to -0.6 V at 0.06 V/s (Figure 
8.9). Notice that these curves are not identical to those in the last cycle of CV in the 
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 corresponding medium. This is due to the mass transfer complications involved in CV 
techniques. The initial potential was chosen where there is almost no oxygen reduction. The final 
potential was chosen where oxygen reduction is supposed to happen at its mass transfer limiting  
 
Table 8.1: Current values at -0.6 V in LSV measurements. 
Current 
values 
(nA) 
0 3 min 6 min 9 min 30 min 1 h 12 h Coefficient 
of 
variation 
PCM 
coated 
electrode 
in PBS 
419 426 434 433 519 547 532 0.12 
PCM 
coated 
electrode 
in BBS 
294 291 285 282 308 297 325 0.05 
Bare 
electrode 
in PBS 
624 538 544 590 865 1098 686 0.29 
Bare 
electrode 
in BBS 
364 357 351 347 413 366 764 0.36 
 
 
rate. Below -0.6 V (especially -0.7 V and below), hydrogen evolution will occur and the gas 
bubbles will destroy the PCM coating. The scan rate was chosen such that the data acquisition 
time is 10 s, neither too short for double-layer charging current to dominate nor too long as 
unnecessary for engineering purposes. In general, the LSV response of the device depends on the 
medium, i.e. the LSV curves obtained in DI water, PBS, and BBS are different. One of the well-
adopted structural models for Nafion describes its microscopic structure as clusters 
interconnected by narrow channels (about 1 nm in diameter) which determine the transport 
properties of ions and water (Gierke et al., 1982). The chemical species present in the aqueous 
medium (e.g. ions, proteins) can affect the molecular structures of the film by either diffusing 
into the channels or adsorbing onto the surface. These processes are associated with the changes 
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 in the CV behaviors during the electrochemical stabilization. The electrochemical stabilization 
process settles the film down to equilibrium or quasi-equilibrium with the medium and makes the 
device become more consistent and show less long term drifting. 
After the first LSV curve was recorded, more LSV curves were taken subsequently at the 
time points of 3 min, 6 min, 9 min, 30 min, 1 h, and 12 h. The current values at -0.6 V are used 
to quantify the electrochemical activity of the electrodes. For comparison, bare Pt electrodes 
were also examined following identical experimental procedures (including electrochemical 
stabilization). Data are shown in Table 8.1. Both the short term and long term performances of 
the PCM coated electrodes are better than those of the bare Pt electrodes. It is unexpected that 
results obtained for PCM coated electrodes in BBS are better than those obtained in PBS, which 
could be observed irrespective of the devices used, the batch of the PBS prepared, the batch of 
the BBS purchased, etc. 
From now on, we will focus on device performance evaluation in BBS which is more 
clinically relevant in long term implantations. Device-to-device variation was examined by LSV 
techniques and results are quantified by the current values at -0.6 V. For PCM coated electrodes, 
the current values at -0.6 V are 247±65 nA (n=10). For bare Pt electrodes, the current values at -
0.6 V are 346±78 nA (n=10). Compared to PCM coated electrodes, the bare Pt electrodes have a 
slightly smaller coefficient of variation (0.23 versus 0.26). However, when long term device 
reliability is placed as the most important consideration, PCM coated electrodes should be used. 
Therefore, from now on we will focus on PCM coated electrodes. Notice that if the current at -
0.6 V is assumed to be the diffusion limited cathodic current, then a relative variation of 26% in 
this current will roughly translate into a relative variation of 26% in the PCM thickness, which is 
consistent with film thickness characterization results in the previous discussion. 
One requirement for an implanted dissolved oxygen sensor is that it should be insensitive 
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 to agitation caused by body fluid convection or patient movement. In our experiments, the device 
was immersed in air-equilibrated BBS contained in a beaker. A magnetic stirrer was used to 
generate forced convection in the solution. The rotation speed of the stir bar was varied from 0 to 
the possible maximum. LSV measurements were carried out and the current values at -0.6 V are 
used to quantify the results. The statistics on measurements with all different rotation speeds 
gives a mean value of 271 nA, a standard deviation of 12 nA, and a coefficient of variation of 
0.04. This variation is acceptable if we take into account that the readings from a single device in 
long term tests in air-equilibrated BBS have a coefficient of variation of 0.05 (see Table 8.1). 
The insensitiveness of the device operation to stirring implies that the oxygen mass transfer 
resistance is dominated by diffusion through the PCM film. 
These micromachined dissolved oxygen sensors were designed and intended for long 
term implantation use. One important target application is post-operative tissue 
microenvironment (e.g. oxygen level) monitoring in free tissue transfers. The oxygen 
concentrations to be monitored in this and most of other medical situations range from 0% atm to 
21% atm (x% atm corresponds to the oxygen concentration in a solution in equilibrium with a 
gas phase of x% atm pure oxygen). For example, in the aforementioned application, 21% atm 
oxygen level indicates the normal condition with well-established blood flow. Near 0% atm 
oxygen level indicates the occurrence of ischemia. For any reliable sensor, any measurement 
should be independent of the measurement history of the sensor. In the case of a dissolved 
oxygen sensor, the reading should depend on the oxygen level in the solution being monitored, 
but not on the oxygen level in the solution previously monitored. We prepared oxygen-depleted 
BBS by purging nitrogen into the solution. The device was alternatively immersed in air-
equilibrated BBS and oxygen-depleted BBS. LSV measurements were carried out and the 
current values at -0.6 V are used to quantify the results. The statistics (Figure 8.10) has shown 
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 that the values obtained in air-equilibrated BBS are consistent with each other and the values 
obtained oxygen-depleted BBS are consistent with each other, regardless of the measurement 
history. The offset currents at the zero oxygen concentration level are primarily caused by device  
 
Figure 8.10: Current values at -0.6 V obtained in air-equilibrated/oxygen-depleted BBS. 
 
 
Figure 8.11: Linear sweep voltammograms obtained in BBS with three different oxygen 
concentration levels. 
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Figure 8.12: Current values from 3 devices at -0.6 V obtained in BBS with three different oxygen 
concentration levels. 
 
capacitance and faradaic side-reactions. The currents obtained in air-equilibrated BBS are 
significantly different from those obtained in oxygen-depleted BBS (p<0.0001). These results 
indicate that the device has the potential to be used in low-level oxygen monitoring. We have 
also observed that, for PCM-based dissolved oxygen sensors, measurements based on PSC 
technique have much larger hysteresis in terms of response to oxygen concentration change. 
The next measurement is to evaluate device linearity and sensitivity. Measurements were 
carried out on 10 devices at 3 different oxygen levels (Figure 8.11). Figure 8.12 shows the data 
for 3 of the devices. For each device, the current/oxygen-concentration has a linear relationship 
as expected. The Pearson product-moment correlation coefficient is calculated for each device 
and the average is found to be 0.996. One problem reflected in Figure 8.12 is device-to-device 
variation. Since single device has shown good linearity, we propose that a two-point calibration 
will be sufficient for each device prior to use. The sensitivity is determined to be 4.7±1.8 nA/(% 
atm oxygen). Another important parameter of a sensor is its resolution. As we have discussed, 
the readings of a single device have approximately 5% fluctuations in long term tests. The 
average reading taken from 10 devices in air-equilibrated BBS is 247 nA (see previous 
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 discussion). The average sensitivity is 4.7 nA/(% atm oxygen). Thus, the resolution of the device 
is roughly equal to 5%×(247nA)/(4.7nA/(% atm oxygen)) = 2.6 % atm oxygen. 
 
 
Figure 8.13: Current values at -0.6 V obtained in normal/lactated BBS. 
 
The potential values of these devices for in vivo use were further examined by looking at 
their in vitro performances in simulated body environment. One important shortcoming of 
experimentation in out-of-body BBS is the lack of physiological responses. For example, when 
ischemia occurs (near zero oxygen concentration), the contents of the local body fluid change 
slightly and unknown small electroactive molecules might be produced and accumulate 
transiently in the body fluid. Despite the fact that these molecules should only be present at very 
low concentrations, it is possible that they can interfere with the oxygen sensing process by one 
way or another. It is well-known that lactate is the most abundantly produced molecules during 
ischemia. As a preliminary study, we compared the responses of the device in air-equilibrated 
BBS and lactated air-equilibrated BBS. Specifically, BBS containing 10 mM sodium lactate was 
prepared by adding sodium lactate to the medium. The device was alternatively immersed in 
normal BBS and lactated BBS and was thoroughly rinsed by DI water when transferred from 
lactated BBS to normal BBS. LSV measurements were carried out and the current values at -0.6 
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 V are used to quantify the results. The statistics reveal that there is no significant difference 
between measurements obtained in the two media (p>0.05) (Figure 8.13). 
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APPENDIX A 
 
SOME MATHEMATICAL DETAILS REGARDING CHAPTER 3 
 
Denote the eigenvalue of matrix (3.19) as z. For any given z, we can obtain two solutions 
with two k values with opposite signs. A parity operation which takes x into –x can transform one 
solution into the other. Therefore, the two k values with opposite signs give physically equivalent 
solutions (mirror solutions with respect to the origin). Matrix (3.19) is a 2×2 matrix and has two 
eigenvalues. Thus there are at most two physically different solutions. To prove that there is at 
least one physically allowed solution, we begin with the characteristic equation of matrix (3.19) 
(which the eigenvalue z must satisfy), 
( ) ( )
2 2
2 2 20 0 0 0
0 0 0 0
0 0
0
1 1
s s
f f f f f
v v v v
iz i z
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Denote the two roots by z1 and z2 and apply Viete’s formulas to equation (A1), 
( )
2
2 0 0
1 2 0 0 0
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f f f
v v
z z i
K K
ω ρ ωφω ρ β ωφ β φ
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 (A2) 
This implies that ( ) ( )0 01 2 1 2 0 0 0Im Im Im 01f vz z z z K
ωφωφ β φ
Φ+ = + = Φ + >− .  
Therefore, either Imz1 or Imz2 has to be greater than zero. Without loss of generality, we assume 
Imz1>0. Then 
1
2
1 1k z=  is a complex number falling into the 1st quadrant of the complex plane 
and represents a wave propagating along and decaying in the +x direction ( 121 1k z= − is a complex 
number falling into the 3rd quadrant of the complex plane and represents a wave propagating 
along and decaying in the -x direction, which is the mirror solution of 121 1k z= ). 
 APPENDIX B 
 
SOME MATHEMATICAL DETAILS REGARDING CHAPTER 4 
 
In this appendix, we present a detailed derivation of the third term on the right hand side 
of equation (4.3), which is a source term representing drug transport across the capillary walls. 
Establish a Cartesian coordinate system such that the x direction is perpendicular to the capillary 
wall and is pointing from the inside of the vessel to the outside of the vessel. Since we are 
dealing with a local problem, we can assume translational invariance in the y and z direction and 
reduce the problem to 1-D. Assume the inner surface of the capillary wall is located at x = 0 and 
the outer surface at x = L. The capillary wall is modeled as a rigid porous medium. Darcy’s law, 
when applied across the capillary wall, is written as 
( )0p p iv L p p= −  (B1) 
where vp is the fluid velocity across the capillary wall. 
Mass conservation in the capillary wall is written as 
( )1 0p pp pc cD c vt x x σ
∂ ∂⎛ ⎞∂+ − + − =⎜ ⎟∂ ∂ ∂⎝ ⎠p  (B2) 
where cp is the drug concentration within the capillary wall, and Dp is the drug diffusion 
coefficient within the capillary wall. 
Since mass transfer across the capillary wall is very slow, we apply the quasi-steady-state 
approximation and reduce equation (B2) to 
( )1 0pp pcD c vx x σ
∂⎛ ⎞∂ − + −⎜ ⎟∂ ∂⎝ ⎠p =  (B3) 
The solution of equation (B3) subject to the boundary conditions of 0p xc c= 0= and p x Lc c= = is 
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where 
( )1 p
mv
p
v L
Pe
D
σ−=  and by definition pD pL= . Using equation (B1), we have 
( ) ( )0 1p i
mv
L p p
Pe
p
σ− −= , which is identical to equation (4.4). 
Under the quasi-steady-state approximation, the drug flux Jp across a single capillary wall is 
independent of x and is given by 
( ) ( ) ( ) ( )0 011
1
mv
mv
Pe
p ip
p p p p Pe
L p p c e cc
J D c v
x e
σσ − − −∂= − + − =∂ −  (B5) 
Therefore the drug source term in equation (4.3) representing drug transport across the capillary 
walls per unit tissue volume should be sJp.
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